967 results on '"Yonekawa A"'
Search Results
2. ACUTE MACULAR NEURORETINOPATHY AFTER SARS-COV-2 VACCINATION
- Author
-
Samir N Patel and Yoshihiro Yonekawa
- Subjects
Pediatrics ,medicine.medical_specialty ,Retinal thickening ,genetic structures ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,General Medicine ,medicine.disease_cause ,eye diseases ,Vaccination ,Ophthalmology ,Immunization ,Rare case ,medicine ,In patient ,business ,Coronavirus - Abstract
Purpose To present the rare case of a patient who developed acute macular neuroretinopathy following administration of a single dose adenovector coronavirus vaccine. Methods Retrospective chart review. Results A 26-year-old woman presented with paracentral scotomas in both eyes that acutely developed two days following administration of a single dose adenovector SARS-CoV-2 vaccine (Johnson & Johnson, New Brunswick, NJ). She had previously received the seasonal influenza immunization without any symptoms and denied any recent history of viral illnesses. On examination, optical coherence tomography showed parafoveal hyperreflective bands in the outer retina of both eyes without retinal thickening, and near-infrared reflectance showed wedge-shaped parafoveal lesions pointing to the fovea, both classic findings in acute macular neuroretinopathy. Discussion This report highlights the development of AMN after a SARS-CoV-2 vaccination in an otherwise healthy female patient. A single case cannot establish cause and effect, and millions of COVID-19 vaccines have been administered safely at the time of writing. However, this may be a rare association, and clinicians can consider inquiring about recent vaccination history in patients presenting with AMN.
- Published
- 2022
3. PRO score: predictive scoring system for visual outcomes after rhegmatogenous retinal detachment repair
- Author
-
Claire Ryan, Luv G. Patel, Diego Arias, Jason Hsu, Carl D. Regillo, Edwin H. Ryan, Geoffrey G. Emerson, Jeffrey Lin, Antonio Capone, Yoshihiro Yonekawa, Michael J Ammar, Dean Eliott, Omesh P. Gupta, Daniel P. Joseph, Nora J. Forbes, Matthew R. Starr, Anthony Obeid, and Louis Z. Cai
- Subjects
medicine.medical_specialty ,Proliferative vitreoretinopathy ,Scoring system ,business.industry ,Preoperative risk ,Retinal detachment repair ,Retinal detachment ,medicine.disease ,Logistic regression ,eye diseases ,Sensory Systems ,Cellular and Molecular Neuroscience ,Ophthalmology ,Internal medicine ,Cohort ,Medicine ,In patient ,business - Abstract
Background/aimsTo compare risk factors for poor visual outcomes in patients undergoing primary rhegmatogenous retinal detachment (RRD) repair and to develop a scoring system.MethodsAnalysis of the Primary Retinal detachment Outcomes (PRO) study, a multicentre interventional cohort of consecutive primary RRD surgeries performed in 2015. The main outcome measure was a poor visual outcome (Snellen VA ≤20/200).ResultsA total of 1178 cases were included. The mean preoperative and postoperative logMARs were 1.1±1.1 (20/250) and 0.5±0.7 (20/63), respectively. Multivariable logistic regression identified preoperative risk factors predictive of poor visual outcomes (≤20/200), including proliferative vitreoretinopathy (PVR) (OR 1.26; 95% CI 1.13 to 1.40), history of antivascular endothelial growth factor (VEGF) injections (1.38; 1.11 to 1.71), >1-week vision loss (1.17; 1.08 to 1.27), ocular comorbidities (1.18; 1.00 to 1.38), poor presenting VA (1.06 per initial logMAR unit; 1.02 to 1.10) and age >70 (1.13; 1.04 to 1.23). The data were split into training (75%) and validation (25%) and a scoring system was developed and validated. The risk for poor visual outcomes was 8% with a total score of 0, 17% with 1, 29% with 2, 47% with 3, and 71% with 4 or higher.ConclusionsIndependent risk factors were compared for poor visual outcomes after RRD surgery, which included PVR, anti-VEGF injections, vision loss >1 week, ocular comorbidities, presenting VA and older age. The PRO score was developed to provide a scoring system that may be useful in clinical practice.
- Published
- 2021
4. GEOGRAPHIC ACCESS DISPARITIES TO CLINICAL TRIALS IN RETINOPATHY OF PREMATURITY IN THE UNITED STATES
- Author
-
Louis Z. Cai, Annika G. Samuelson, Theodore Bowe, John W. Hinkle, Samir N Patel, Rebecca R. Soares, Yoshihiro Yonekawa, Devayu Parikh, and Catherine K. Liu
- Subjects
medicine.medical_specialty ,education.field_of_study ,Multivariate analysis ,business.industry ,Population ,Retinopathy of prematurity ,General Medicine ,Odds ratio ,medicine.disease ,Clinical trial ,Ophthalmology ,Quartile ,Epidemiology ,medicine ,business ,education ,Socioeconomic status ,Demography - Abstract
BACKGROUND/PURPOSE To identify geographic and socioeconomic variables predictive of residential proximity to retinopathy of prematurity (ROP) clinical trial locations. METHODS This cross-sectional epidemiological study used census tract-level data from three national public data sets and trial-level data from ClinicalTrials.gov. Socioeconomic predictors of driving distance and time to the nearest ROP clinical trial location were identified. Primary outcomes were time >60 minutes and distance >60 miles traveled to the nearest ROP clinical trial site. RESULTS Multivariate analysis showed that residents were more likely to travel >60 minutes to the nearest ROP clinical trial site if they lived in census tracts that were rural (adjusted odds ratio 1.20, P = 0.0002), had higher percentages of the population living ≤ federal poverty level (fourth quartile vs. first quartile, adjusted odds ratio 1.19, P 60 minutes. Similar variables predicted travel distance. CONCLUSION Although counties with higher incidences of very low-birth-weight infants were closer to ROP clinical trial sites, residents living in rural and low-income census tracts had significantly greater travel burdens.
- Published
- 2021
5. Cryoballoon ablation for atrial fibrillation without the use of a contrast medium: a combination of the intracardiac echocardiography and pressure wave monitoring guided approach
- Author
-
Toyoaki Murohara, Takatsugu Hiramatsu, Hitoshi Ichimiya, Satoshi Yanagisawa, Satoshi Ichimiya, Daiki Yamashita, Yasuya Inden, Junji Watanabe, Yuichiro Makino, Jun Yonekawa, Yasuhiro Uchida, Masanari Kurobe, Akinori Satake, Masaaki Kanashiro, and Yoshiaki Mizutani
- Subjects
medicine.medical_specialty ,media_common.quotation_subject ,medicine.medical_treatment ,Cryosurgery ,Recurrence ,Internal medicine ,Atrial Fibrillation ,Occlusion ,Humans ,Contrast (vision) ,Medicine ,Fluoroscopy ,Retrospective Studies ,media_common ,medicine.diagnostic_test ,business.industry ,Atrial fibrillation ,Vascular surgery ,Ablation ,medicine.disease ,Cardiac surgery ,Contrast medium ,Treatment Outcome ,Echocardiography ,Pulmonary Veins ,Catheter Ablation ,cardiovascular system ,Cardiology ,Cardiology and Cardiovascular Medicine ,business - Abstract
In cryoballoon ablation (CBA), a contrast medium is commonly used to confirm balloon occlusion of the pulmonary veins (PVs). However, a contrast medium cannot always be used in patients with renal dysfunction and allergy. The present study aimed to assess the efficacy and safety of CBA without the use of a contrast medium. We retrospectively examined consecutive patients with paroxysmal atrial fibrillation (PAF) who underwent first-time CBA. We compared the procedural results and outcomes in patients for whom a contrast medium was used (contrast group) and those from whom a contrast medium was not used (non-contrast group). In the non-contrast group, we used saline injection on the intracardiac echocardiography and pressure wave monitoring for PV occlusion. Fifty patients (200 PVs) and 22 patients (88 PVs) underwent CBA with and without a contrast medium, respectively. The success rate of PV isolation with CBA alone was 93% and 90% in the non-contrast and contrast groups, respectively (p = 0.40). The fluoroscopy time and nadir temperature were significantly lower in the non-contrast group as compared to that in the contrast group. The recurrence rate 1 year after ablation did not differ between the two groups (18% vs. 18%, p > 0.99). Furthermore, the number of reconnected PVs in patients with recurrence was significantly lower in the non-contrast group than in the contrast group (6% vs. 36%, p = 0.017). In conclusion, CBA using the intracardiac echocardiography and pressure monitoring approach without the use of a contrast medium was safe and efficient.
- Published
- 2021
6. Earliest pulmonary vein potential‑guided cryoballoon ablation is associated with better clinical outcomes than conventional cryoballoon ablation: A result from two randomized clinical studies
- Author
-
Takatsugu Hiramatsu, Junji Watanabe, Yasuhiro Uchida, Satoshi Yanagisawa, Toyoaki Murohara, Satoshi Ichimiya, Jun Yonekawa, Hitoshi Ichimiya, Daiki Yamashita, Yuichiro Makino, Yasuya Inden, Masaaki Kanashiro, and Yoshiaki Mizutani
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Atrial fibrillation ,medicine.disease ,Balloon ,Ablation ,Cryosurgery ,Pulmonary vein ,Surgery ,Treatment Outcome ,Pulmonary Veins ,Recurrence ,Physiology (medical) ,Baseline characteristics ,Atrial Fibrillation ,Catheter Ablation ,medicine ,Clinical endpoint ,Humans ,Cardiology and Cardiovascular Medicine ,business ,Cryoballoon ablation ,Randomized Controlled Trials as Topic ,Paroxysmal AF - Abstract
INTRODUCTION With regard to short-term outcome in atrial fibrillation (AF), the benefit of cryoballoon ablation (CBA) by pressing a balloon against the earliest pulmonary vein (PV) potential site during PV isolation (earliest potential [EP]-guided CBA) has been previously demonstrated. The present study aimed to evaluate the long-term outcome of the EP-guided CBA. METHODS AND RESULTS This study included 136 patients from two randomized studies, who underwent CBA for paroxysmal AF for the first time. Patients were randomly assigned to the EP-guided and conventional CBA groups in each study. In the EP-guided CBA group, we pressed a balloon against the EP site when the time-to-isolation (TTI) after cryoapplication exceeded 60 and 45 s in the first and second studies, respectively. We compared the clinical outcomes for 1 year after the procedure between the EP-guided CBA group (68 patients) and the conventional CBA group (68 patients). The primary endpoint was the recurrence of atrial arrhythmia after ablation. No significant differences in baseline characteristics were observed between the two groups. Compared with the conventional CBA group, the EP-guided CBA group had a significantly higher success rate at TTI ≤ 90 s (98.5% vs. 90.0%, p
- Published
- 2021
7. Traumatic Retinal Detachment in Patients with Self-Injurious Behavior
- Author
-
Polly A. Quiram, Jay Chhablani, Eric Nudleman, Dominic M. Buzzacco, Aaron Nagiel, Kirk Hou, Peter J. Belin, Timothy G. Murray, Safa Rahmani, Jacob Lifton, Michael J. Shapiro, Jean-Pierre Hubschman, Thomas Lee, Irena Tsui, Jessica Goldstein, Yoshihiro Yonekawa, C. Armitage Harper, Wei-Chi Wu, Emmanuel Chang, Philip J. Ferrone, Natalia Arruti, Supalert Prakhunhungsit, Ella H. Leung, Alexander L. Ringeisen, Sui Chien Wong, Audina M. Berrocal, Karl R. Olsen, Robert H. Henderson, Lisa L. Leishman, Elizabeth J. Rossin, Shunji Kusaka, Michael P. Blair, and Linda A. Cernichiaro-Espinosa
- Subjects
0303 health sciences ,Proliferative vitreoretinopathy ,medicine.medical_specialty ,Visual acuity ,business.industry ,medicine.medical_treatment ,Retinal detachment ,Retinal ,Vitrectomy ,medicine.disease ,Scleral buckle ,eye diseases ,03 medical and health sciences ,Ophthalmology ,chemistry.chemical_compound ,0302 clinical medicine ,chemistry ,030221 ophthalmology & optometry ,medicine ,Tamponade ,medicine.symptom ,Phthisis bulbi ,business ,030304 developmental biology - Abstract
Purpose To describe the clinical characteristics, surgical outcomes, and management recommendations in patients with traumatic rhegmatogenous retinal detachment (RRD) resulting from self-injurious behavior (SIB). Design International, multicenter, retrospective, interventional case series. Participants Patients with SIB from 23 centers with RRD in at least 1 eye. Methods Clinical histories, preoperative assessment, surgical details, postoperative management, behavioral intervention, and follow-up examination findings were reviewed. Main Outcome Measures The rate of single-surgery anatomic success (SSAS) was the primary outcome. Other outcomes included new RRD in formerly attached eyes, final retinal reattachment, and final visual acuity. Results One hundred seven eyes with RRDs were included from 78 patients. Fifty-four percent of patients had bilateral RRD or phthisis bulbi in the fellow eye at final follow-up. The most common systemic diagnoses were autism spectrum disorder (35.9%) and trisomy 21 (21.8%) and the most common behavior was face hitting (74.4%). The average follow-up time was 3.3 ± 2.8 years, and surgical outcomes for operable eyes were restricted to patients with at least 3 months of follow-up (81 eyes). Primary initial surgeries were vitrectomy alone (33.3%), primary scleral buckle (SB; 26.9%), and vitrectomy with SB (39.7%), and 5 prophylactic SBs were placed. Twenty-three eyes (21.5%) with RRDs were inoperable. The SSAS was 23.1% without tamponade (37.2% if including silicone oil), and final reattachment was attained in 80% (36.3% without silicone oil tamponade). Funnel-configured RRD (P = 0.006) and the presence of grade C proliferative vitreoretinopathy (P = 0.002) correlated with re-detachment. The use of an SB predicted the final attachment rate during the initial surgery (P = 0.005) or at any surgery (P = 0.008. These associations held if restricting to 64 patients with ≥12 months followup. Anatomic reattachment correlated with better visual acuity (P Conclusions RRD resulting from SIB poses therapeutic challenges because of limited patient cooperation, bilateral involvement, chronicity, and ongoing trauma in vulnerable and neglected patients. The surgical success rates were some of the lowest in the modern retinal detachment literature. The use of an SB may result in better outcomes, and visual function can be restored in some patients.
- Published
- 2021
8. Scleral Buckling for Primary Retinal Detachment: Outcomes of Scleral Tunnels versus Scleral Sutures
- Author
-
Starr, Matthew R., Ryan, Edwin H., Obeid, Anthony, Ryan, Claire, Gao, Xinxiao, Madhava, Malika L., Maloney, Sean M., Adika, Adam Z., Peddada, Krishi V., Sioufi, Kareem, Patel, Luv G., Ammar, Michael J., Forbes, Nora J., Capone Jr., Antonio, Emerson, Geoffrey G., Joseph, Daniel P., Eliott, Dean, Regillo, Carl D., Hsu, Jason, Gupta, Omesh P., Yonekawa, Yoshihiro, and Study Group, for the Primary Retinal Detachment Outcomes (PRO)
- Subjects
medicine.medical_specialty ,Visual acuity ,genetic structures ,medicine.medical_treatment ,Vitrectomy ,Scleral buckle ,Scleral Suture ,Suture (anatomy) ,Scleral Buckle ,Ophthalmology ,medicine ,Strabismus ,Rhegmatogenous Retinal Detachment ,business.industry ,Retinal detachment ,Retrospective cohort study ,RE1-994 ,medicine.disease ,eye diseases ,Sclera ,Scleral Tunnels ,medicine.anatomical_structure ,Original Article ,sense organs ,medicine.symptom ,business - Abstract
Purpose: There are primarily two techniques for affixing the scleral buckle (SB) to the sclera in the repair of rhegmatogenous retinal detachment (RRD): scleral tunnels or scleral sutures. Methods: This retrospective study examined all patients with primary RRD who were treated with primary SB or SB combined with vitrectomy from January 1, 2015 through December 31, 2015 across six sites. Two cohorts were examined: SB affixed using scleral sutures versus scleral tunnels. Pre- and postoperative variables were evaluated including visual acuity, anatomic success, and postoperative strabismus. Results: The mean preoperative logMAR VA for the belt loop cohort was 1.05 ± 1.06 (Snellen 20/224) and for the scleral suture cohort was 1.03 ± 1.04 (Snellen 20/214, p = 0.846). The respective mean postoperative logMAR VAs were 0.45 ± 0.55 (Snellen 20/56) and 0.46 ± 0.59 (Snellen 20/58, p = 0.574). The single surgery success rate for the tunnel cohort was 87.3% versus 88.6% for the suture cohort (p = 0.601). Three patients (1.0%) in the scleral tunnel cohort developed postoperative strabismus, but only one patient (0.1%) in the suture cohort (p = 0.04, multivariate p = 0.76). All cases of strabismus occurred in eyes that underwent SB combined with PPV (p = 0.02). There were no differences in vision, anatomic success, or strabismus between scleral tunnels versus scleral sutures in eyes that underwent primary SB. Conclusion: Scleral tunnels and scleral sutures had similar postoperative outcomes. Combined PPV/SB in eyes with scleral tunnels might be a risk for strabismus post retinal detachment surgery.
- Published
- 2021
9. Ossifying fibromyxoid tumor in an elderly patient: A case report and literature review
- Author
-
Yukiko Kusuyama, Yoshihiro Morita, Narikazu Uzawa, Atsuko Niki-Yonekawa, Hiroyuki Yano, Takaki Iwagami, and Nobuo Morita
- Subjects
medicine.medical_specialty ,business.industry ,Radiography ,030206 dentistry ,Trunk ,Pathology and Forensic Medicine ,Lesion ,stomatognathic diseases ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,stomatognathic system ,Otorhinolaryngology ,030220 oncology & carcinogenesis ,Ossifying fibromyxoid tumor ,Medicine ,Surgery ,Radiology ,Oral Surgery ,medicine.symptom ,business ,Head and neck ,Elderly patient ,Dental alveolus ,Subcutaneous tissue - Abstract
An ossifying fibromyxoid tumor (OFMT) is a rare mesenchymal neoplasm of borderline malignant potential that usually arises in the subcutaneous tissue of the extremities, trunk, and head and neck area; it is extremely rare in the oral cavity. OFMTs occur in adults, mostly middle-aged, and are slightly more common in men, with a median age of approximately 50 years. A case of an OFMT of the gingiva in the maxillary molar area in an elderly patient is presented. An 88-year-old woman presented to our department with a painless swelling of the gingiva in the right maxillary molar area. Radiography showed a lesion with absorption of the right maxillary alveolar bone. The lesion was removed from the maxillary gingiva under general anesthesia. The histopathological diagnosis was OFMT. A patient with OFMT needs long-term postoperative follow-up because it has a recurrence rate of about 30 %.
- Published
- 2021
10. Comparative Incidence of Postoperative Hemorrhage in Vitreoretinal Surgery in Patients on Anti-Coagulants
- Author
-
Allen C. Ho, Yoshihiro Yonekawa, Allen Chiang, Sunir J. Garg, Nicholas Boucher, Carl D. Regillo, Jason Hsu, Matthew R. Starr, Michael J. Ammar, and Luv G. Patel
- Subjects
Pars plana ,medicine.medical_specialty ,genetic structures ,medicine.drug_class ,medicine.medical_treatment ,Vitrectomy ,Postoperative Hemorrhage ,Vitreoretinal Surgery ,Postoperative Complications ,medicine ,Humans ,In patient ,Retrospective Studies ,Intraocular hemorrhage ,business.industry ,Incidence ,Incidence (epidemiology) ,Anticoagulant ,Vitreoretinal surgery ,medicine.disease ,eye diseases ,Surgery ,medicine.anatomical_structure ,On anti-coagulants ,business - Abstract
BACKGROUND AND OBJECTIVE: Data regarding hemorrhagic complications of direct oral anticoagulants (DOACs) and vitreoretinal surgery are limited. PATIENTS AND METHODS: Multicenter analysis of longitudinal, aggregated electronic health records of patients undergoing pars plana vitrectomy (PPV) with no prior history of ocular hemorrhage. Retrospective analysis of patients undergoing PPV between January 1, 2013, and December 31, 2019. The main outcomes were development of postoperative hemorrhagic complications within 1 month following vitreoretinal surgery. RESULTS: A total of 58,131 eyes underwent PPV, with 2,956 (5.1%) on anticoagulant medication prior to surgery. Eight hundred twenty-eight eyes (1.4%) developed a postoperative hemorrhage. Of eyes with anticoagulation use, 50 of 2,956 (1.29%) developed a hemorrhage, whereas 778 of 55,175 (1.41%) of the eyes with no prior anticoagulation use developed a postoperative hemorrhage ( P = .2107). CONCLUSION: Use of DOACs prior to vitreoretinal surgery does not appear to be associated with increased rates of postoperative intraocular hemorrhage. [ Ophthalmic Surg Lasers Imaging Retina . 2021;52:374–379.]
- Published
- 2021
11. Novel adsorptive type apheresis device Immunopure for ulcerative colitis from clinical perspectives based on clinical trials: Japan and Europe
- Author
-
Yusuke Inoue, Shunichi Yanai, Kazutaka Kukita, Yoshihiro Endo, Kazuya Kitamura, Keisuke Kawasaki, Izumi Hasegawa, Motoki Yonekawa, Ken Kawakami, Masaki Katagiri, Hiroki Nakamura, Kazuhito Kani, Takayuki Matsumoto, Shingo Kato, Tomonari Ogawa, Takuya Doi, Kazuhide Higuchi, and Kazuki Kakimoto
- Subjects
Male ,medicine.medical_specialty ,moderate ,Clinical effectiveness ,Polyesters ,therapeutic apheresis ,030232 urology & nephrology ,030204 cardiovascular system & hematology ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Refractory ,Internal medicine ,Humans ,Medicine ,In patient ,Platelet activation ,Cellulose ,ulcerative colitis ,Polyethylene Terephthalates ,adsorptive device ,business.industry ,Remission Induction ,aggregation ,polyarylate resin ,Equipment Design ,Original Articles ,Hematology ,medicine.disease ,Ulcerative colitis ,Europe ,Clinical Practice ,Clinical trial ,Apheresis ,granulocyte ,Nephrology ,monocyte ,Blood Component Removal ,Colitis, Ulcerative ,Female ,Original Article ,Adsorption ,business ,leukocyte - Abstract
Several adsorptive type devices for ulcerative colitis are used for the induction of remission in patients with active severe disease worldwide. In 2020, the novel apheresis device Immunopure for ulcerative colitis was launched in Japan. Immunopure, like the polyethylene terephthalate column, uses polyarylate, a type of polyester resin, as the adsorbent. Similar to the cellulose acetate column, Immunopure is filled with adsorbent beads and expected to provide ease of use, with minimal risk of column clogging. Immunopure adsorbs leukocytes and platelets, especially activated platelets and platelet‐leukocyte aggregates. In this article, the capability of Immunopure is evaluated from clinical perspective based on a clinical trial in Japan/Europe. As a result, Immunopure is comparable to other products in clinical effectiveness and indicated for the treatment of patients with refractory moderate ulcerative colitis, making it highly useful in clinical practice.
- Published
- 2021
12. Predictors of fatal outcome after severe necrotizing fasciitis: Retrospective analysis in a tertiary hospital for 20 years
- Author
-
Katsushi Takeshita, Hiroshi Kurabayashi, Hirokazu Inoue, Kensuke Minami, Chikara Yonekawa, Takashi Mato, Tomohiro Matsumura, Tsuneari Takahashi, and Susumu Adachi
- Subjects
Disseminated intravascular coagulation ,Arteriosclerosis obliterans ,medicine.medical_specialty ,Heart disease ,business.industry ,medicine.medical_treatment ,Odds ratio ,medicine.disease ,Tertiary Care Centers ,Sepsis ,Risk Factors ,Internal medicine ,Humans ,Medicine ,Orthopedics and Sports Medicine ,Surgery ,Fasciitis, Necrotizing ,business ,Fasciitis ,Body mass index ,Dialysis ,Retrospective Studies - Abstract
Background Prognostic factors for fatal outcomes of patients with necrotizing fasciitis remain unclear. Methods We retrospectively analyzed data of patients with necrotizing fasciitis from January 1998 to July 2019 using our hospital's medical database. Clinical characteristics of patients who died during hospitalization or had been discharged were evaluated. Sex, age, body mass index, smoking history, alcohol use, comorbidities (diabetes mellitus, arteriosclerosis obliterans, heart disease, obstructive arteriosclerosis, dialysis, cancer, skin disease, steroid use history), shock vital, physical findings, Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score, sepsis, disseminated intravascular coagulation, fascial administration, tracheal intubation, and surgical treatment (dismemberment and/or debridement) were compared between the survivor (group S) and nonsurvivor (group N) groups. Results Fifty-five patients with necrotizing fasciitis were included (40 patients in group S and 15 patients in group N). Serum creatine was a significant prognostic factor (odds ratio [OR], 3.03; 95% confidence interval [CI], 0.15–0.75; P = 0.0078), with a cutoff value of 1.56 mg/dL. Moreover, the estimated glomerular filtration rate was a significant prognostic factor (OR, 1.06; 95% CI, 1.02–1.10, P = 0.000548), with a cutoff value of 20.6 mL/min. Conclusion Renal dysfunction is a significant prognostic factor for fatal outcomes of patients with necrotizing fasciitis. Level of Evidence Level IV, Case series.
- Published
- 2021
13. Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for status epilepticus: study protocol for a multicenter non-inferiority designed randomized control trial
- Author
-
Kensuke Nakamura, Aiki Marushima, Yuji Takahashi, Akio Kimura, Masahiro Asami, Satoshi Egawa, Junya Kaneko, Yutaka Kondo, Chikara Yonekawa, Eisei Hoshiyama, Takeshi Yamada, Kazushi Maruo, Yoshiaki Inoue, and IENE ECT with the LIFE study group
- Subjects
Phenytoin ,Adult ,Medicine (General) ,Levetiracetam ,Medicine (miscellaneous) ,Status epilepticus ,law.invention ,03 medical and health sciences ,Epilepsy ,Study Protocol ,0302 clinical medicine ,Status Epilepticus ,R5-920 ,Randomized controlled trial ,Japan ,law ,Fosphenytoin ,medicine ,Humans ,Multicenter Studies as Topic ,Pharmacology (medical) ,030212 general & internal medicine ,Adverse effect ,Randomized Controlled Trials as Topic ,Diazepam ,business.industry ,medicine.disease ,Seizure ,Clinical trial ,Treatment Outcome ,Anesthesia ,Anticonvulsants ,medicine.symptom ,Neoplasm Recurrence, Local ,business ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Background Status epilepticus (SE) is an emergency condition for which rapid and secured cessation is important. Phenytoin and fosphenytoin, the prodrug of phenytoin with less severe adverse effects, have been recommended as second-line treatments. However, fosphenytoin causes severe adverse events, such as hypotension and arrhythmia. Levetiracetam reportedly has similar efficacy and higher safety for SE; however, evidence to support its use for adult SE is lacking. In the present study, a non-inferiority designed multicenter randomized controlled trial (RCT) is being conducted to compare levetiracetam with fosphenytoin after diazepam as a second-line treatment for SE. Methods This multicenter, prospective, and open-label RCT is conducted in emergency departments. Between December 23, 2019, and March 31, 2023, 176 patients with convulsive SE transported to an emergency room will be randomized into a fosphenytoin group and levetiracetam group at a ratio of 1:1. The definition of SE is “continuous seizures longer than 5 min or discrete seizures longer than 2 min with intervening consciousness disturbance.” In both groups, diazepam is initially administered at 1–20 mg, followed by intravenous fosphenytoin at 22.5 mg/kg or intravenous levetiracetam at 1000–3000 mg. The primary outcome is the seizure cessation rate within 30 min. Seizure recurrence within 24 h, severe adverse events, and intubation rate within 24 h are secondary outcomes. Discussion The present study was approved and conducted as an initiative study of the Japanese Association for Acute Medicine. If non-inferiority is identified, the society will pursue an application for the national health insurance coverage of levetiracetam for SE via a public knowledge-based application. Trial registration Japan Registry of Clinical Trials jRCTs031190160. Registered on December 13, 2019
- Published
- 2021
14. CHARACTERISTICS AND SURGICAL OUTCOMES OF RHEGMATOGENOUS RETINAL DETACHMENT IN OLDER ADULTS
- Author
-
Anthony Obeid, Antonio Capone, Carl D. Regillo, Nora J. Forbes, Yoshihiro Yonekawa, Matthew R. Starr, Dean Eliott, Rebecca R. Soares, Edwin H. Ryan, Omesh P. Gupta, Claire Ryan, Geoffrey G. Emerson, Luv G. Patel, Jason Hsu, Daniel P. Joseph, Michael J Ammar, and Samir N Patel
- Subjects
Adult ,Pars plana ,medicine.medical_specialty ,Proliferative vitreoretinopathy ,Visual acuity ,Pseudophakia ,genetic structures ,medicine.medical_treatment ,Visual Acuity ,Vitrectomy ,Endotamponade ,Intraoperative Period ,03 medical and health sciences ,chemistry.chemical_compound ,Age Distribution ,0302 clinical medicine ,Ophthalmology ,medicine ,Humans ,030212 general & internal medicine ,Aged ,Retrospective Studies ,Aged, 80 and over ,business.industry ,Age Factors ,Retinal Detachment ,Outcome measures ,Retinal detachment ,Retinal ,General Medicine ,Middle Aged ,medicine.disease ,Treatment Outcome ,medicine.anatomical_structure ,chemistry ,030221 ophthalmology & optometry ,medicine.symptom ,business ,Follow-Up Studies ,Cohort study - Abstract
PURPOSE To describe characteristics and outcomes of primary rhegmatogenous retinal detachment in older adults (age ≥ 80). METHODS Consecutive patients with rhegmatogenous retinal detachment undergoing pars plana vitrectomy (PPV), scleral buckling (SB), or PPV/SB in the Primary Retinal Detachment Outcomes Study were evaluated. Outcome measures included single surgery anatomic success and visual acuity. RESULTS Of 2,144 patients included, 125 (6%) were 80 years or older. Compared with younger patients (age 40-79), older adults were more likely to be pseudophakic (P < 0.001), have macula-off detachments (P < 0.001), and have preoperative proliferative vitreoretinopathy (P = 0.02). In older adults, initial surgery was PPV in 73%, PPV/SB in 27%, and primary SB in 0%. Single surgery anatomic success was 78% in older adults compared with 84% in younger patients (P = 0.03). In older adults, single surgery anatomic success was 74% for PPV and 91% for PPV/SB (P = 0.03). The final mean logMAR was lower for older adults (0.79 [20/125] vs. 0.40 [20/40], [P < 0.001]). In older adults, the final mean logMAR for eyes that underwent PPV was 0.88 (20/160) compared with 0.50 (20/63) for PPV/SB (P = 0.03). CONCLUSION Octogenarians and nonagenarians presented with relatively complex pseudophakic rhegmatogenous retinal detachments. Single surgery anatomic success and visual outcomes were worse compared with younger patients, and PPV/SB had better outcomes compared with PPV alone.
- Published
- 2021
15. Opioids and ophthalmology: review of the current literature
- Author
-
Yoshihiro Yonekawa, Luv G. Patel, Matthew R. Starr, and Michael J. Ammar
- Subjects
Opioid epidemic ,medicine.medical_specialty ,business.industry ,Opioid use ,Postoperative pain ,General Medicine ,03 medical and health sciences ,Ophthalmology ,0302 clinical medicine ,Opioid ,Prescription opioid ,Health care ,030221 ophthalmology & optometry ,Medicine ,Medical prescription ,business ,030217 neurology & neurosurgery ,medicine.drug ,Ophthalmic surgery - Abstract
Purpose of review The number of opioid-related overdose deaths has rapidly increased since 2000, increasing more than five-fold from 1999 to 2016. Although surgeons only write 10% of opioid prescriptions annually, with ophthalmologists writing only a fraction of this amount, all physicians need to be cognizant of the current opioid epidemic and ways to decrease unnecessary opioid prescriptions. Recent findings Previous work within ophthalmology has shown that retrobulbar anesthesia along with peri-operative intravenous or oral nonopioid analgesics can lead to decreased postoperative opioid use following ophthalmic surgery. Recent literature has shifted focus towards the use of opioid prescription guidelines in managing postoperative pain and decreasing the number of unnecessary opioids being prescribed by ophthalmologists. Overall, the frequency of opioid prescriptions may have gradually declined the past few years with such efforts, increased awareness, and new healthcare policies to monitor opioid prescriptions. However, ophthalmologists still continue to prescribe a substantial number of opioid medications, much of which may not be necessary. Summary This review serves as a tool to aid all ophthalmologists in managing postoperative pain. There is a recent trend in addressing the opioid epidemic and efforts are being made to limit the overprescribing of opioids. Continued efforts are still required by all ophthalmologists to address the current opioid epidemic.
- Published
- 2021
16. RETINAL DETACHMENT WITH INFERIOR RETINAL BREAKS
- Author
-
Michael J Ammar, Daniel P. Joseph, Anthony Obeid, Jason Hsu, Carl D. Regillo, Yoshihiro Yonekawa, Omesh P. Gupta, Nora J. Forbes, Claire Ryan, Luv G. Patel, Matthew R. Starr, Edwin H. Ryan, Dean Eliott, Geoffrey G. Emerson, and Antonio Capone
- Subjects
Pars plana ,Retinal breaks ,medicine.medical_specialty ,genetic structures ,medicine.medical_treatment ,Vitrectomy ,Scleral buckle ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Study report ,Ophthalmology ,medicine ,030212 general & internal medicine ,business.industry ,Primary vitrectomy ,Retinal detachment ,Retinal ,General Medicine ,medicine.disease ,eye diseases ,medicine.anatomical_structure ,chemistry ,030221 ophthalmology & optometry ,business - Abstract
Introduction Rhegmatogenous retinal detachments with inferior retinal breaks are believed to have a higher risk of recurrent rhegmatogenous retinal detachment. This study compared anatomic and visual outcomes between primary pars plana vitrectomy (PPV) and combination PPV with scleral buckle (PPV/SB) for rhegmatogenous retinal detachments with inferior retinal breaks. Methods This is an analysis of the Primary Retinal Detachment Outcomes study, a multi-institutional cohort study of consecutive primary rhegmatogenous retinal detachment surgeries from January 1, 2015, through December 31, 2015. The primary outcome was single-surgery success rate. Only eyes with inferior retinal breaks (one break in the detached retina between five and seven o'clock) were included. Results There were 238 eyes that met the inclusion criteria, 95 (40%) of which underwent primary PPV and 163 (60%) that underwent combined PPV/SB. The single-surgery success rate was 76.8% for PPV and 87.4% for PPV/SB (P = 0.0355). This remained significant on multivariate analysis (P = 0.01). Subgroup analysis showed that a superior single-surgery success rate of PPV/SB was especially noted in phakic eyes (85.2% vs. 68.6%; P = 0.0464). Conclusion Retinal detachment with inferior retinal breaks had a higher single-surgery success rate if treated with PPV/SB compared with PPV alone, particularly in phakic eyes.
- Published
- 2021
17. Management of Inflamed Conjunctival Nevus with Topical Antiallergic Medications: Case Series
- Author
-
Yuka Yonekawa, Kumiko Kato, Yuzen Kashima, Maki Takeuchi, Mineo Kondo, and Koji Hirano
- Subjects
medicine.medical_specialty ,Conjunctiva ,business.industry ,Epinastine ,epinastine ,Clinical Ophthalmology ,Methods observational ,eye diseases ,Tacrolimus ,Resection ,Ophthalmology ,inflamed juvenile conjunctival nevus ,Conjunctival Nevus ,medicine.anatomical_structure ,Antiallergic agent ,Edema ,Medicine ,Case Series ,sense organs ,medicine.symptom ,tacrolimus ,business ,medicine.drug - Abstract
Kumiko Kato,1 Maki Takeuchi,1 Yuka Yonekawa,1 Yuzen Kashima,1 Koji Hirano,2 Mineo Kondo1 1Department of Ophthalmology, Mie University Graduate School of Medicine, Tsu, Japan; 2Department of Ophthalmology, Fujita Health University Bantane Hospital, Nagoya, JapanCorrespondence: Kumiko KatoDepartment of Ophthalmology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, JapanTel +81-59-231-5027Fax +81-59-231-3036Email k-kato@clin.medic.mie-u.ac.jpPurpose: To report our findings in three cases of an inflamed conjunctival nevus whose size and degree of pigmentation were reduced by topical antiallergic and immunosuppressive ophthalmic solutions.Methods: Observational case series. Three patients with inflamed conjunctival nevus were examined by slit-lamp biomicroscopy, and the findings before and after the treatments were compared.Results: All three patients had a slightly pigmented and edematous conjunctival tumor at the corneal limbal area. The tumors were hyperemic, and papillae and follicles were present on the superior conjunctiva in all patients. All of the patients had an allergic predisposition. The antiallergic treatment not only resolved the hyperemia and edema of the palpebral conjunctiva, but also reduced the tumor size. In one case, the topical antiallergic agent alone led to a reduction of the tumor size. A combination of topical antiallergic agent and topical immunosuppressant was effective in reducing the tumor size and degree of pigmentation in the other two patients.Conclusion: The hyperemia and pigmentation in eyes with inflamed conjunctival nevus can be resolved by topical antiallergic agent and topical immunosuppressant without resection of the tumor.Keywords: inflamed juvenile conjunctival nevus, epinastine, tacrolimus
- Published
- 2021
18. Impact of the clinical frailty scale on clinical outcomes and bleeding events in patients with ST-segment elevation myocardial infarction
- Author
-
Yasuhiro Uchida, Jun Yonekawa, Takatsugu Hiramatsu, Junji Watanabe, Hideki Ishii, Akinori Satake, Tatsuaki Matsubara, Hitoshi Ichimiya, Daiki Yamashita, Koji Mizutani, Masaaki Kanashiro, Tetsuya Amano, Satoshi Ichimiya, Masanari Kurobe, Yuichiro Makino, Toyoaki Murohara, and Yoshiaki Mizutani
- Subjects
Male ,musculoskeletal diseases ,medicine.medical_specialty ,Time Factors ,medicine.medical_treatment ,Population ,Postoperative Hemorrhage ,030204 cardiovascular system & hematology ,03 medical and health sciences ,Percutaneous Coronary Intervention ,0302 clinical medicine ,Japan ,Risk Factors ,Internal medicine ,medicine ,Humans ,Prospective Studies ,Registries ,cardiovascular diseases ,030212 general & internal medicine ,Myocardial infarction ,education ,Aged ,Retrospective Studies ,education.field_of_study ,Frailty ,business.industry ,Incidence ,Incidence (epidemiology) ,Hazard ratio ,virus diseases ,Percutaneous coronary intervention ,Middle Aged ,medicine.disease ,Confidence interval ,nervous system diseases ,Conventional PCI ,ST Elevation Myocardial Infarction ,Female ,Cardiology and Cardiovascular Medicine ,business ,human activities ,Mace ,Follow-Up Studies - Abstract
The Clinical Frailty Scale (CFS) is a simple tool to assess patients' frailty and may help to predict adverse outcomes in elderly patients. The aim of the present study was to examine the impact of CFS on clinical outcomes and bleeding events after successful percutaneous coronary intervention (PCI) in ST-segment elevation myocardial infarction (STEMI). We enrolled 266 consecutive patients with STEMI who underwent primary PCI in between January 2015 and June 2018. Patients were categorized into two groups based on the CFS stages: CFS 1-3 and CFS ≥ 4. We collected the data and evaluated the relationship between the CFS grade and the incidence of major adverse cardiovascular events (MACE) and Bleeding Academic Research Consortium 3 or 5 bleeding events. Of these patients, CFS ≥ 4 was present in 59 (22.2%). During the follow-up, 37.3% in the CFS ≥ 4 group and 8.2% in the CFS 1-3 group experienced MACE. In Kaplan–Meier analysis, the proportion of MACE-free survival for 4 years was significantly lower in the CFS ≥ 4 group (log-rank P
- Published
- 2021
19. Association of CYP1A1 and CYP1B1 inhibition in in vitro assays with drug-induced liver injury
- Author
-
Michiko Watanabe, Kouichi Yoshinari, Eri Yonekawa, Jun-ichi Takeshita, Yuki Shimizu, Takuomi Hosaka, Hirokazu Yamazaki, Ryota Shizu, Rui Ogura, and Takamitsu Sasaki
- Subjects
Liver injury ,Drug ,biology ,business.industry ,media_common.quotation_subject ,CYP1B1 ,In vitro toxicology ,Cytochrome P450 ,010501 environmental sciences ,Pharmacology ,Toxicology ,medicine.disease ,030226 pharmacology & pharmacy ,01 natural sciences ,Discontinuation ,03 medical and health sciences ,0302 clinical medicine ,Drug development ,polycyclic compounds ,medicine ,biology.protein ,business ,Drug metabolism ,0105 earth and related environmental sciences ,media_common - Abstract
Drug-induced liver injury (DILI) is one of the major causes for the discontinuation of drug development and withdrawal of drugs from the market. Since it is known that reactive metabolite formation and being substrates or inhibitors of cytochrome P450s (P450s) are associated with DILI, we systematically investigated the association between human P450 inhibition and DILI. The inhibitory activity of 266 DILI-positive drugs (DILI drugs) and 92 DILI-negative drugs (no-DILI drugs), which were selected from Liver Toxicity Knowledge Base (US Food and Drug Administration), against 8 human P450 forms was assessed using recombinant enzymes and luminescent substrates, and the threshold values showing the highest balanced accuracy for DILI discrimination were determined for each P450 enzyme using receiver operating characteristic analyses. The results showed that among the P450s tested, CYP1A1 and CYP1B1 were inhibited by DILI drugs more than no-DILI drugs with a statistical significance. We found that 91% of drugs that showed inhibitory activity greater than the threshold values against CYP1A1 or CYP1B1 were DILI drugs. The results of internal 5-fold cross-validation confirmed the usefulness of CYP1A1 and CYP1B1 inhibition data for the threshold-based discrimination of DILI drugs. Although the contribution of these P450s to drug metabolism in the liver is considered minimal, our present findings suggest that the assessment of CYP1A1 and CYP1B1 inhibition is useful for screening DILI risk of drug candidates at the early stage of drug development.
- Published
- 2021
20. <scp> PIGO </scp> variants in a boy with features of Mabry syndrome who also exhibits Fryns syndrome with peripheral neuropathy
- Author
-
Yuhki Koike, Yoshiko Murakami, Keiichi Uchida, Yoshihide Mitani, Takahiro Ito, Hirofumi Sawada, Mikihiro Inoue, Taroh Kinoshita, Noriko Yodoya, Taro Okuda, Kohei Matsushita, Hiroyuki Ohashi, Shotaro Iwamoto, Takahiro Yonekawa, and Masahiro Hirayama
- Subjects
medicine.medical_specialty ,Peripheral neuropathy ,business.industry ,Fryns syndrome ,Genetics ,Mabry syndrome ,medicine ,medicine.disease ,business ,Dermatology ,Genetics (clinical) - Published
- 2020
21. Large1 gene transfer in older myd mice with severe muscular dystrophy restores muscle function and greatly improves survival
- Author
-
Adam J. Rauckhorst, Mary E. Anderson, Alvin D. Pewa, Sara El-Hattab, Eric B. Taylor, Hidehiko Okuma, David Venzke, Takahiro Yonekawa, Marco Cuellar, and Kevin P. Campbell
- Subjects
medicine.medical_specialty ,Neuromuscular disease ,Glucuronosyltransferase ,Multidisciplinary ,biology ,business.industry ,Skeletal muscle ,medicine.disease ,Pathophysiology ,Extracellular matrix ,Endocrinology ,medicine.anatomical_structure ,Laminin ,Internal medicine ,biology.protein ,medicine ,Respiratory function ,Muscular dystrophy ,business - Abstract
Muscular dystrophy is a progressive and ultimately lethal neuromuscular disease due to lack of therapeutic options that restore muscle function. Gene editing and gene transfer hold great promise as therapies for various neuromuscular diseases when administered prior to the onset of severe clinical symptoms. However, the efficacy of these strategies for restoring neuromuscular function and improving survival in the late stages of muscular dystrophy with severe muscle pathophysiology is unknown. Dystroglycanopathies are muscular dystrophies characterized by extensive skeletal muscle degeneration and, in many cases, are accompanied by eye and brain abnormalities. Thus far, mutations in at least eighteen human genes are known to cause dystroglycanopathies, including those in the like-acetylglucosaminyltransferase-1 (LARGE1) gene. LARGE1 encodes a xylosyl- and glucuronosyltransferase that modifies α-dystroglycan (α-DG) with matriglycan, a linear repeating disaccharide of alternating xylose and glucuronic acid that binds to the laminin G-like domains of extracellular matrix proteins with high affinity. Largemyd/Largemyd (myd) mice lack expression of Large1, and exhibit severe skeletal muscle pathophysiology, impaired mobility, and a drastically reduced lifespan (50% survivorship at 35 weeks of age). Here, we show that systemic delivery of AAV2/9 CMV Large1 (AAVLarge1) in >34-week-old myd mice with advanced disease restores matriglycan expression, attenuates skeletal muscle pathophysiology, improves motor and respiratory function, and normalizes systemic metabolism, which collectively and dramatically extends survival. Our results demonstrate that in a mouse model of muscular dystrophy, skeletal muscle function can be restored, illustrating its remarkable plasticity, and that survival can be greatly improved even after the onset of severe skeletal muscle pathophysiology.
- Published
- 2022
22. Primary Retinal Detachment Outcomes Study: Pseudophakic Retinal Detachment Outcomes
- Author
-
Carl D. Regillo, Jason Hsu, Omesh P. Gupta, D. Wilkin Parke, Geoffrey G. Emerson, Antonio Capone, Kevin J. Blinder, Sushant Wagley, George A. Williams, Yoshihiro Yonekawa, Nora J. Forbes, Dean Eliott, Daniel P. Joseph, Gaurav K. Shah, Robert A. Mittra, Claire Ryan, and Edwin H. Ryan
- Subjects
Pars plana ,Proliferative vitreoretinopathy ,medicine.medical_specialty ,genetic structures ,business.industry ,medicine.medical_treatment ,Retinal detachment ,Vitrectomy ,medicine.disease ,Scleral buckle ,eye diseases ,Retinal Tear ,Ophthalmology ,medicine.anatomical_structure ,Glaucoma surgery ,Medicine ,sense organs ,Tamponade ,business - Abstract
Purpose This study evaluates outcomes of comparable pseudophakic rhegmatogenous retinal detachment (RRD) treated with pars plana vitrectomy (PPV) or PPV with scleral buckle (PPV-SB). Design Multicenter, retrospective, interventional cohort study. Participants Data were gathered from patients from multiple retina practices in the United States with RRD in 2015. Methods A large detailed database was generated. Pseudophakic patients with RRD managed with PPV or PPV-SB were analyzed for anatomic and visual outcomes. Eyes with proliferative vitreoretinopathy, giant retinal tears, previous invasive glaucoma surgery, and ≤90 days of follow-up were excluded from outcomes analysis. Single surgery anatomic success (SSAS) was defined as retinal attachment without ongoing tamponade and with no other RRD surgery within 90 days. Main Outcome Measures Single surgery anatomic success and final Snellen visual acuity (VA). Results A total of 1158 of 2620 eyes (44%) with primary RRD were pseudophakic. A total of 1018 eyes had greater than 90 days of follow-up. Eyes with proliferative vitreoretinopathy, previous glaucoma surgery, and giant retinal tears were excluded, leaving 893 pseudophakic eyes eligible for outcome analysis. A total of 461 (52%) were right eyes. A total of 606 patients (67%) were male, with a mean age of 65±11 years. Pars plana vitrectomy and PPV-SB as the first procedure were performed on 684 eyes (77%) and 209 eyes (23%), respectively. The mean follow-up was 388±161 days, and overall SSAS was achieved in 770 eyes (86%). Single surgery anatomic success was 84% (577/684) for PPV and 92% (193/209) for PPV-SB. The difference in SSAS between types of treatment was significant (P = 0.009). In eyes with macula-on RRD, SSAS was 88% in eyes treated with PPV and 100% in eyes treated with PPV-SB (P = 0.0088). In eyes with macula-off RRD, SSAS was 81% in eyes treated with PPV and 89% in eyes treated with PPV-SB (P = 0.029). Single surgery anatomic success was greater for PPV-SB than PPV for inferior (96% vs. 82%) and superior (90% vs. 82%) detachments. Mean final VA was similar for PPV (20/47) and PPV-SB (20/46; P = 0.805). Conclusions In pseudophakic RRDs, SSAS was better in patients treated with PPV-SB compared with PPV alone, whereas visual outcomes were similar for both groups.
- Published
- 2020
23. The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score
- Author
-
Atsushi Ogura, Toshiki Mukai, Masato Nagino, Yoshihiko Yonekawa, Yukihiro Yokoyama, Kay Uehara, Tomoki Ebata, Yasuhiro Kodera, Takashi Mizuno, and Toshisada Aiba
- Subjects
0301 basic medicine ,Oncology ,medicine.medical_specialty ,Multivariate analysis ,Colorectal cancer ,medicine.medical_treatment ,Population ,Subgroup analysis ,03 medical and health sciences ,0302 clinical medicine ,Surgical oncology ,Internal medicine ,medicine ,Hepatectomy ,Humans ,education ,Retrospective Studies ,Chemotherapy ,education.field_of_study ,Centimeter ,business.industry ,Liver Neoplasms ,Hematology ,General Medicine ,medicine.disease ,Neoadjuvant Therapy ,Tumor Burden ,Treatment Outcome ,030104 developmental biology ,Chemotherapy, Adjuvant ,030220 oncology & carcinogenesis ,Surgery ,Colorectal Neoplasms ,business - Abstract
The indications for neoadjuvant chemotherapy (NAC) in resectable colorectal liver metastases (CRLMs) remain unclear. Tumor burden score (TBS) is a prognostic tool based on tumor size and number of tumors. However, its utility in the NAC setting for initially resectable CRLM has never been investigated. TBS is a distance from the origin on a Cartesian plane to the coordinates (x, y) = (tumor size in centimeter, number of tumors). TBS
- Published
- 2020
24. Posterior Retinotomy vs Perfluorocarbon Liquid to Aid Drainage of Subretinal Fluid During Primary Rhegmatogenous Retinal Detachment Repair (PRO Study Report No. 10)
- Author
-
Yoshihiro Yonekawa, Geoffrey G. Emerson, Omesh P. Gupta, Loi V. Vo, Dean Eliott, Edwin H. Ryan, Antonio Capone, Abdhish R. Bhavsar, Gaurav K. Shah, Claire Ryan, Jacob M. Jones, and M. Vaughn Emerson
- Subjects
0301 basic medicine ,Pars plana ,medicine.medical_specialty ,genetic structures ,business.industry ,medicine.medical_treatment ,Retinal detachment repair ,Retinal detachment ,Vitrectomy ,medicine.disease ,eye diseases ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,medicine.anatomical_structure ,Study report ,Ophthalmology ,030221 ophthalmology & optometry ,medicine ,Perfluorocarbon liquid ,Original Manuscripts ,sense organs ,Subretinal fluid ,business - Abstract
Purpose: This work compares posterior retinotomy vs perfluorocarbon liquid (PFCL) for subretinal fluid (SRF) drainage during pars plana vitrectomy for primary rhegmatogenous retinal detachment (RRD). Methods: In this large, multicenter, retrospective comparative study, 2620 patients underwent pars plana vitrectomy (with or without scleral buckle) for uncomplicated RRD. Patients for whom SRF was drained via the primary break without retinotomy or PFCL were excluded; those who required both retinotomy and PFCL were similarly excluded. Remaining patients were separated into “retinotomy” and “PFCL” cohorts. Subgroup analysis was conducted for macula-on and macula-off subgroups. Postoperative outcomes were analyzed and compared. Results: A total of 760 eyes (82.7%) had retinotomy and 159 eyes (17.3%) had PFCL for drainage of SRF, and baseline characteristics between the 2 groups were similar. Postoperative analysis showed similar outcomes between the retinotomy and PFCL cohorts, including final visual acuity ( P = .19), redetachment rate ( P = .30), anatomic success ( P = .28), presence of postoperative epiretinal membrane ( P = .75), and other macular pathologies ( P > .99). Subgroup analysis yielded similar outcomes for macula-on and macula-off subgroups. Postoperative presence of retained PFCL was 2.4%, possibly a factor in the slightly higher number of subsequent surgical procedures ( P = .03) in the PFCL cohort. Conclusions: Postoperative outcomes for retinotomy vs PFCL during RRD repair are comparable, aside from slightly greater number of subsequent surgical procedures needed in the PFCL cohort. Our analysis suggests both techniques are reasonable tools in the repair of macula-on or macula-off RRD.
- Published
- 2020
25. Primary Retinal Detachment Outcomes Study: Methodology and Overall Outcomes—Primary Retinal Detachment Outcomes Study Report Number 1
- Author
-
Gaurav K. Shah, Kevin J. Blinder, Edwin H. Ryan, D. Wilkin Parke, Robert A. Mittra, George A. Williams, Geoffrey G. Emerson, Daniel P. Joseph, Claire Ryan, Omesh P. Gupta, Dean Eliott, Alex Ringeisen, Nora J. Forbes, Jason Hsu, Yoshihiro Yonekawa, Carl D. Regillo, and Antonio Capone
- Subjects
Male ,Pars plana ,medicine.medical_specialty ,genetic structures ,medicine.medical_treatment ,Visual Acuity ,Vitrectomy ,Subgroup analysis ,Postoperative Complications ,Case mix index ,Ophthalmology ,medicine ,Humans ,Retrospective Studies ,business.industry ,Retinal Detachment ,Reproducibility of Results ,Retinal detachment ,Retrospective cohort study ,Middle Aged ,medicine.disease ,eye diseases ,Scleral Buckling ,medicine.anatomical_structure ,Cohort ,Female ,business ,Follow-Up Studies ,Cohort study - Abstract
Purpose To detail the methodology for a large multicenter retrospective cohort study (RCS) of primary rhegmatogenous retinal detachment (RRD) with detailed data collection and to present overall anatomic outcomes. Design This study used an RCS method. Participants All patients undergoing pars plana vitrectomy (PPV), scleral buckling (SB), and combined PPV/SB for primary RRD in 2015 from 5 large retina groups were included in the database. Methods To ensure validity of the cohort method, a large and detailed database was generated. Double data entry validation was conducted, and data audits were conducted. Anatomic and visual outcomes for all the cases in the dataset will be described but not compared, because the cases were not matched. In future studies, comparable cases of moderate-complexity RRD will be chosen naive to surgeon, surgery, and outcome for subgroup analysis. Main Outcome Measures Precision of data entry was confirmed by inter-rater reliability (IRR). Main surgical outcome for each procedure type was single-surgery anatomic success (SSAS). Results Inter-rater reliability showed significant agreement among raters (P 90 days of follow-up. Of these, 320 eyes (13.7%) underwent SB, 1200 eyes (51.4%) underwent PPV, and 815 eyes (34.9%) underwent PPV/SB. The SSAS was 84.2% for PPV, 91.2% for SB, and 90.2% for PPV/SB. Conclusions We compiled a large, accurately documented database of primary RRD cases repaired by PPV, SB, and PPV/SB from which cohort studies of moderately complex RRDs can be carried out. All 3 approaches had a high SSAS rate. Procedures chosen and their outcomes are described, but the broad case mix makes comparisons not possible until future cohort studies are completed.
- Published
- 2020
26. Primary Retinal Detachment Outcomes Study Report Number 2
- Author
-
Yoshihiro Yonekawa, D. Wilkin Parke, Kevin J. Blinder, Dean Eliott, Jason Hsu, Gaurav K. Shah, Carl D. Regillo, Daniel P. Joseph, Sushant Wagley, Geoffrey G. Emerson, Edwin H. Ryan, Robert A. Mittra, Antonio Capone, Nora J. Forbes, Claire Ryan, George A. Williams, and Omesh P. Gupta
- Subjects
Pars plana ,medicine.medical_specialty ,Proliferative vitreoretinopathy ,Visual acuity ,genetic structures ,medicine.medical_treatment ,Vitrectomy ,Scleral buckle ,03 medical and health sciences ,0302 clinical medicine ,Ophthalmology ,medicine ,030304 developmental biology ,0303 health sciences ,business.industry ,Retinal detachment ,Retrospective cohort study ,medicine.disease ,eye diseases ,medicine.anatomical_structure ,Vitreous hemorrhage ,030221 ophthalmology & optometry ,sense organs ,medicine.symptom ,business - Abstract
Purpose Anatomically similar rhegmatogenous retinal detachments (RRDs) can be treated with scleral buckle (SB), pars plana vitrectomy (PPV), or SB combined with PPV (PPV/SB). This study compares moderately complex phakic primary RRD treated with SB, PPV, or PPV/SB to review anatomic and visual outcomes. Design Multicenter, retrospective, interventional cohort study. Participants Data were gathered on all patients from multiple retina practices in the United States with RRD in 2015 and >90 days of follow-up. The cohort of phakic patients with moderately complex RRD was analyzed. Methods A large and detailed database was generated. Eyes with findings that would bias toward PPV (vitreous hemorrhage, dense cataract, proliferative vitreoretinopathy, giant retinal tear, among others) were excluded. Age Main Outcome Measures Single surgery anatomic success (SSAS), defined as retinal attachment with no other RRD surgery within 90 days, is the main outcome measure. Final visual acuity is the secondary outcome measure. Pearson’s chi-square and analysis of variance were used to test treatment effect of surgery type on SSAS and vision. Results Single surgery anatomic success was noted in 155 of 169 SB cases (91.7%), 207 of 249 PPV cases (83.1%), and 271 of 297 PPV/SB cases (91.2%). Scleral buckle and PPV/SB were superior to PPV for SSAS (P = 0.0041). For macula-on or split cases, SB had significantly better visual outcomes than PPV or PPV/SB even after controlling for cataract (cases with minimal cataract at final follow-up or after cataract surgery) (P Conclusions For phakic moderately complex primary RRDs in this study of PPV versus SB versus PPV/SB, SB had the best visual outcomes, and PPV had the worst SSAS outcomes.
- Published
- 2020
27. Clinical evaluation of fully automated molecular diagnostic system 'Simprova' for influenza virus, respiratory syncytial virus, and human metapneumovirus
- Author
-
Kunihiro Oba, Yuji Segawa, Yoshitaka Sawada, Shinji Saito, Akihiro Terada, Keiichi Kiya, Shohei Semba, Masashi Shiomi, Kiyotaka Murakami, Hideyuki Kubo, Atsushi Kaida, Kota Yokono, Hidetoshi Watanabe, Sadasaburo Asai, Tsutomu Kageyama, Toshihiro Yonekawa, Tsugunori Notomi, Ikuyo Takayama, Katsushi Kaji, and Mina Nakauchi
- Subjects
Male ,0301 basic medicine ,Adolescent ,Point-of-care testing ,030106 microbiology ,Loop-mediated isothermal amplification ,lcsh:Medicine ,Microbiology ,Virus ,Article ,Automation ,03 medical and health sciences ,0302 clinical medicine ,Antigen ,Human metapneumovirus ,Humans ,Medicine ,Nucleic Acid Amplification Tests ,030212 general & internal medicine ,Respiratory system ,Child ,lcsh:Science ,Multidisciplinary ,biology ,Respiratory tract infections ,business.industry ,lcsh:R ,Infant, Newborn ,Health care ,Infant ,Orthomyxoviridae ,biology.organism_classification ,Publisher Correction ,Virology ,Respiratory Syncytial Viruses ,Molecular Diagnostic Techniques ,Child, Preschool ,Female ,lcsh:Q ,Metapneumovirus ,business ,Nucleic Acid Amplification Techniques - Abstract
Influenza virus, respiratory syncytial virus, and human metapneumovirus commonly cause acute upper and lower respiratory tract infections, especially in children and the elderly. Although rapid antigen detection tests for detecting these infections have been introduced recently, these are less sensitive than nucleic acid amplification tests. More recently, highly sensitive point-of-care testings (POCTs) have been developed based on nucleic acid amplification tests, which are easy to use in clinical settings. In this study, loop-mediated isothermal amplification (LAMP)-based POCT “Simprova” to detect influenza A and B viruses, respiratory syncytial virus, and human metapneumovirus was developed. Simprova system is fully automated and does not require skilled personnel. In addition, positive results can be achieved faster than with PCR. In this study, the accuracy of the POCT was retrospectively analyzed using 241 frozen stocked specimens. Additionally, the usability of the Simprova at clinical sites was assessed in a prospective clinical study using 380 clinical specimens and compared to those of real-time PCR and rapid antigen detection test. The novel LAMP-based POCT demonstrated high sensitivity and specificity in characterizing clinical specimens from patients with influenza-like illnesses. The Simprova is a powerful tool for early diagnosis of respiratory viral infections in point-of-care settings.
- Published
- 2020
28. Ophthalmology conferences in the coronavirus disease 2019 era
- Author
-
Yoshihiro Yonekawa, Jayanth Sridhar, Mrinali P. Gupta, and Charles C. Wykoff
- Subjects
medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Pneumonia, Viral ,Space (commercial competition) ,computer.software_genre ,Betacoronavirus ,Videoconferencing ,Continuing medical education ,Ophthalmology ,medicine ,Humans ,Audience participation ,Adaptation (computer science) ,Pandemics ,Dissemination ,SARS-CoV-2 ,business.industry ,COVID-19 ,General Medicine ,Congresses as Topic ,Virtual conference ,Coronavirus Infections ,business ,computer - Abstract
Purpose of review To discuss key considerations involved in adapting an in-person ophthalmology conference to a virtual medium. Recent findings In 2020, several ophthalmological societies have held or are planning to hold virtual conferences in lieu of their previously scheduled in-person ophthalmology conference because of the coronavirus disease 2019 pandemic. The strategic meeting components attempted to be retained in these transitions include educational information disseminating, academic discussion with colleagues, sponsorships, and networking. Live-streamed components of a virtual conference may be entirely real time or may include a combination of both prerecorded and live-streamed components. A virtual meeting may offer either a single live-streamed program or several concurrent live-streamed programs from which attendees can choose. The availability of on-demand content, mechanisms for audience participation, avenues for industry interaction and contribution, registration costs, and continuing medical education credit availability vary between virtual meeting formats. Summary Transition of an in-person ophthalmology conference to a virtual format with retention of the inherent value associated with the meeting is possible and the experiences of societies executing this adaptation can be helpful for others entering this space. There are numerous considerations regarding meeting format and logistics to contemplate in light of each meeting's specific audience and objectives.
- Published
- 2020
29. Rationale for American Society of Retina Specialists Best Practice Recommendations for Conducting Vitreoretinal Surgery During the Coronavirus Disease-19 Era
- Author
-
Nicholas Yannuzzi, Yoshihiro Yonekawa, Charles C. Wykoff, Audina M. Berrocal, Amani A. Fawzi, Prithvi Mruthyunjaya, Natalie A. Afshari, David N. Zacks, Jayanth Sridhar, Timothy G. Murray, Aaron F. Carlin, Daniel S W Ting, Yasha S. Modi, Steven Yeh, Brad P. Barnett, Stephen Gayer, Theodore Leng, Ajay E. Kuriyan, and Daniel L. Chao
- Subjects
medicine.medical_specialty ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Best practice ,Vitreoretinal surgery ,Article ,03 medical and health sciences ,0302 clinical medicine ,030221 ophthalmology & optometry ,medicine ,030212 general & internal medicine ,Intensive care medicine ,business - Abstract
Purpose: This review details the rationale behind recommendations recently published by the American Society of Retina Specialists (ASRS) and outlines best practices for safety of vitreoretinal surgeons and staff while performing vitreoretinal surgery during the coronavirus disease 2019 (COVID-19) pandemic. Methods: The Committee for ASRS Best Practices for Retinal Surgery During the COVID-19 Pandemic reviewed existing evidence and information on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission and risk factors during vitreoretinal surgery. Recommendations were based on best available published data, cumulative clinical experiences, and recommendations and policies from other organizations. The Grading of Recommendations Assessment, Development and Evaluation approach was used to assess the strength of recommendations and confidence in the evidence. These serve as interim recommendations that will be routinely updated given the current gaps of knowledge and lack of high-quality data on this evolving subject. Results: Relevant existing literature related to methods of transmission and ocular manifestations of SARS-CoV-2 are summarized. The data and clinical experiences driving recommendations for preoperative, intraoperative, and postoperative surgical considerations and anesthesia choice as well as considerations for intravitreal injections are provided. Conclusions: Recommendations are provided with the goal of protecting vitreoretinal surgeons and associated personnel from exposure to SARS-CoV-2 during interventional vitreoretinal procedures. This is a rapidly evolving topic with numerous remaining gaps in our current knowledge. As such, recommendations will evolve and the present article is intended to serve as a foundation for continued dialogue on best practices.
- Published
- 2020
30. Impact of integrated clinical decision support systems in the management of pediatric acute kidney injury: a pilot study
- Author
-
Karyn Yonekawa, Kristen Carlin, Hong Wu, Rod Tarrago, and Shina Menon
- Subjects
Creatinine ,Drug doses ,medicine.medical_specialty ,business.industry ,MEDLINE ,Acute kidney injury ,urologic and male genital diseases ,medicine.disease ,Clinical decision support system ,female genital diseases and pregnancy complications ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,chemistry ,Electronic health record ,030225 pediatrics ,Pediatrics, Perinatology and Child Health ,Emergency medicine ,Intravascular volume status ,Medicine ,Stage (cooking) ,business ,030217 neurology & neurosurgery - Abstract
BACKGROUND Acute kidney injury (AKI) is common but not often recognized. Early recognition and management may improve patient outcomes. METHODS This is a prospective, nonrandomized study of clinical decision support (CDS) system [combining electronic alert and standardized care pathway (SCP)] to evaluate AKI detection and progression in hospitalized children. The study was done in three phases: pre-, intervention (CDS) and post. During CDS, text-page with AKI stage and link to SCP was sent to patient's contact provider at diagnosis of AKI using creatinine. The SCP provided guidelines on AKI management [AEIOU: Assess cause of AKI, Evaluate drug doses, Intake-Output charting, Optimize volume status, Urine dipstick]. RESULTS In all, 239 episodes of AKI in 225 patients (97 females, 43.1%) were analyzed. Proportion of patients with decrease in the stage of AKI after onset was 71.4% for CDS vs. 64.4% for pre- and 55% for post-CDS phases (p = 0.3). Documentation of AKI was higher during CDS (74.3% CDS vs. 47.5% pre- and 57.5% post-, p
- Published
- 2020
31. Late-Onset Retinal Findings and Complications in Untreated Retinopathy of Prematurity
- Author
-
Polly A. Quiram, Josh E. Robinson, Mark K. Walsh, Sidney A. Schechet, Linda A. Cernichiaro-Espinosa, Charles M. Calvo, Danny A. Mammo, C. Armitage Harper, Mrinali P. Gupta, Audina M. Berrocal, Omar Moinuddin, J. Peter Campbell, Eric R. Holz, Andres Kychenthal, Joseph A. Khawly, Yoshihiro Yonekawa, Cindy Ung, Thomas C. Lee, Michael J. Shapiro, Mary Elizabeth Hartnett, Supalert Prakhunhungsit, Shizuo Mukai, Cagri G. Besirli, Emmanuel Chang, Ryan C. Young, Aaron Nagiel, Abdualrahman E. Hamad, Eric Nudleman, and Michael P. Blair
- Subjects
Adult ,Male ,medicine.medical_specialty ,Time Factors ,Visual acuity ,Adolescent ,genetic structures ,Fundus Oculi ,Visual Acuity ,Retinoschisis ,Retina ,Article ,Young Adult ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Ophthalmology ,medicine ,Humans ,Retinopathy of Prematurity ,Fluorescein Angiography ,Child ,Prospective cohort study ,Aged ,Retrospective Studies ,030304 developmental biology ,0303 health sciences ,medicine.diagnostic_test ,business.industry ,Retinal Detachment ,Gestational age ,Retinal ,Retinopathy of prematurity ,Middle Aged ,Retinal Perforations ,Fluorescein angiography ,medicine.disease ,eye diseases ,Retinal Tear ,chemistry ,Disease Progression ,030221 ophthalmology & optometry ,Female ,sense organs ,medicine.symptom ,business - Abstract
To investigate late retinal findings and complications of eyes with a history of retinopathy of prematurity (ROP) that did not meet treatment criteria and did not receive treatment during infancy.Retrospective, nonconsecutive, noncomparative, multicenter case series.Three hundred sixty-three eyes of 186 patients.Data were requested from multiple providers on premature patients with a history of ROP and no treatment during infancy who demonstrated late retinal findings or complications and included age, gender, gestational age and weight, zone and stage at infancy, visual acuity, current retina vascularization status, vitreous character, presence of peripheral retinal findings such as lattice retinal tears and detachments (RDs), retinoschisis, and fluorescein findings.Rate of RDs and factors conferring a higher risk of RDs.The average age was 34.5 years (range, 7-76 years), average gestational age was 26.6 weeks (range, 23-34 weeks), and average birth weight was 875 g (range, 425-1590 g). Findings included lattice in 196 eyes (54.0%), atrophic holes in 126 eyes (34.7%), retinal tears in 111 eyes (30.6%), RDs in 140 eyes (38.6 %), tractional retinoschisis in 44 eyes (11.9%), and visible vitreous condensation ridge-like interface in 112 eyes (30.5%). Fluorescein angiography (FA) was performed in 113 eyes, of which 59 eyes (52.2%) showed leakage and 16 eyes (14.2%) showed neovascularization. Incomplete vascularization posterior to zone 3 was common (71.6% of eyes). Retinal detachments were more likely in patients with a gestational age of 29 weeks or less (P0.05) and in eyes with furthest vascularization to posterior zone 2 eyes compared with zone 3 eyes (P = 0.009).Eyes with ROP not meeting the treatment threshold during infancy showed various late retinal findings and complications, of which RDs were the most concerning. Complications were seen in all age groups, including patients born after the Early Treatment for Retinopathy of Prematurity Study. Contributing factors to RDs included atrophic holes within peripheral avascular retina, visible vitreous condensation ridge-like interface with residual traction, and premature vitreous syneresis. We recommend regular examinations and consideration of ultra-widefield FA examinations. Prospective studies are needed to explore the frequency of complications and benefit of prophylactic treatment and if eyes treated with anti-vascular endothelial growth factor therapy are at risk of similar findings and complications.
- Published
- 2020
32. Scleral fixated secondary intraocular lenses: a review of recent literature
- Author
-
Luv G. Patel, Matthew R. Starr, Yoshihiro Yonekawa, and Michael J Ammar
- Subjects
medicine.medical_specialty ,genetic structures ,medicine.medical_treatment ,Suture fixation ,Intraocular lens ,03 medical and health sciences ,0302 clinical medicine ,Lens Implantation, Intraocular ,Ophthalmology ,medicine ,Humans ,Lenses, Intraocular ,business.industry ,Suture Techniques ,Retinal detachment ,Retrospective cohort study ,General Medicine ,Scleral fixation ,medicine.disease ,eye diseases ,Intraocular lenses ,030221 ophthalmology & optometry ,sense organs ,business ,Sclera ,030217 neurology & neurosurgery - Abstract
Purpose of review A variety of techniques exist for secondary intraocular lens (IOL) implantation. Of note, scleral fixated intraocular lenses have become more popular with a variety of techniques, both with and without use of sutures. Herein, we focus on reviewing recently published studies describing the long-term outcomes of scleral fixation techniques. Recent findings Although initial papers describing novel techniques often report short-term outcomes, several studies have recently described intermediate and long-term outcomes for scleral fixated IOLs, albeit all being retrospective case series. Suture fixation methods with long-term follow-up, up to a minimum of 50 months, report dislocation rates between 0 and 15%. Sutureless scleral fixation techniques have increased in popularity the past several years. Although they appear to have a lower rate of IOL dislocation: several studies have reported 0% and one study 8%. The follow-up period for sutureless scleral fixation technique studies, however, is shorter with most studies reporting follow-up of less than a year. Rates of retinal detachment vary between individual studies, but are similar for both suture fixation and sutureless with the majority of studies reporting a rate between 0 and 5%. These studies show that long-term outcomes are important considerations in surgical decision-making. Summary Scleral fixation techniques have shown long-term durability and safety in recent retrospective studies. Comparison of techniques has been limited, and more robust studies may be required to provide stronger anatomic, functional, and comparative data.
- Published
- 2020
33. CTNNB1 (β-CATENIN) VITREORETINOPATHY: IMAGING CHARACTERISTICS AND SURGICAL MANAGEMENT
- Author
-
Yoshihiro Yonekawa, Boontip Tipsuriyaporn, and Michael J Ammar
- Subjects
Pediatrics ,medicine.medical_specialty ,Microcephaly ,Familial Exudative Vitreoretinopathies ,MEDLINE ,01 natural sciences ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,medicine ,Humans ,0101 mathematics ,beta Catenin ,Genetic testing ,Multimodal imaging ,medicine.diagnostic_test ,business.industry ,010102 general mathematics ,Chronic rhinitis ,Retinal Detachment ,Infant ,Retinal Vessels ,Retinal ,General Medicine ,medicine.disease ,Ophthalmology ,chemistry ,Catenin ,Failure to thrive ,030221 ophthalmology & optometry ,Female ,medicine.symptom ,business - Abstract
Purpose We report a patient with CTNNB1-associated vitreoretinopathy. We discuss imaging findings and surgical management. Methods Case report. Results An 18-month-old girl with microcephaly, failure to thrive, developmental delay, and chronic rhinitis presented with bilateral central and peripheral tractional retinal detachments and an anomalous retinal vasculature. She underwent multimodal imaging and genetic testing, and we discuss successful surgical management. Conclusion CTNNB1 mutations can cause a vision-threatening vitreoretinopathy. We recommend CTNNB1 to be considered as part of the workup of patients presenting with familial exudative vitreoretinopathy-like clinical findings, especially if there are systemic manifestations.
- Published
- 2020
34. A case of secretory breast cancer in a 6 year-old girl: is it possible to make a correct preoperative diagnosis?
- Author
-
Takumi Gohara, Hironobu Yonekawa, Kazuko Obana, Takahiro Hasebe, Keisuke Ishizawa, Tetsuro Kodaka, Takaki Emura, Makoto Komura, Toshiaki Saeki, Kan Terawaki, Chih-Ping Li, Hiroaki Komuro, Atsushi Sasaki, Hitoshi Tsuda, Aya Asano, Akihiko Osaki, and Toru Kikuchi
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Biopsy ,Breast Neoplasms ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,Surgical oncology ,Preoperative Care ,medicine ,Humans ,Outpatient clinic ,Pharmacology (medical) ,Radiology, Nuclear Medicine and imaging ,Child ,skin and connective tissue diseases ,medicine.diagnostic_test ,business.industry ,Carcinoma ,General Medicine ,medicine.disease ,030104 developmental biology ,Fine-needle aspiration ,Oncology ,Nipples ,030220 oncology & carcinogenesis ,Elasticity Imaging Techniques ,Female ,Radiology ,Elastography ,Breast carcinoma ,business ,Secretory Breast Carcinoma - Abstract
Secretory breast carcinoma constitutes the majority of breast cancers in children and young people less than 20 years of age. Noninvasive examination is particularly necessary for the diagnosis of breast carcinoma in children. Herein, we report a case of secretory breast carcinoma in a 6-year-old girl with psychomotor retardation. She was referred to our outpatient clinic for evaluation of a palpable mass in her left breast. A hard mass, rather than the increase in size typical of premature thelarche, was palpated. An excision biopsy was performed. Pathological findings revealed an invasive secretory breast carcinoma. We performed a retrospective review of the preoperative findings of this case, and compared it to the pathological diagnosis. Elastography, which can be performed without deep sedation or general anesthesia and without causing pain, resulted in a stiffness score of 4; however, the distinction between benign and malignant tumors on elastography, which is important to decide the intra-operative procedures, was not sufficient according to the Japanese breast cancer society clinical guidelines. This is the first report of secretory breast carcinoma in a child with a stiffness score determined by tissue elasticity imaging. A breast mass in a child with a high stiffness score of more than 4 on elastography should be referred for invasive diagnostic procedures, such as fine needle aspiration or excisional biopsy. According to our experience, an accurate preoperative diagnosis could be possible for malignant breast tumors in children. Such parameters as stiffness score on elastography are practical, noninvasive, and objective diagnostic tools for the accurate preoperative diagnosis of breast tumors in children.
- Published
- 2020
35. Clinicopathological analysis of patients with pT3・pT4a squamous cell carcinoma of the oral tongue with muscular invasion
- Author
-
Noriko Yamamoto, Hirofumi Fukushima, Akira Seto, Yu Koizumi, Hiroyuki Yonekawa, Tohru Sasaki, Hiroki Mitani, Yukinori Kimura, Wataru Shinbashi, and Kazuyuki Araki
- Subjects
Pathology ,medicine.medical_specialty ,medicine.anatomical_structure ,Oncology ,Otorhinolaryngology ,business.industry ,Tongue ,Medicine ,Basal cell ,business - Published
- 2020
36. Familial Exudative Vitreoretinopathy: An Update on Genetics and Imaging
- Author
-
Samir N Patel and Yoshihiro Yonekawa
- Subjects
Ophthalmology ,medicine.medical_specialty ,Retinal Diseases ,business.industry ,Familial Exudative Vitreoretinopathies ,Familial exudative vitreoretinopathy ,medicine ,MEDLINE ,Humans ,Fluorescein Angiography ,medicine.disease ,business ,Dermatology - Published
- 2020
37. A DNN-Based Cross-Domain Recommender System for Alleviating Cold-Start Problem in E-Commerce
- Author
-
Takuya Makeawa, Mori Kurokawa, Hanxin Wang, Hao Niu, Kei Yonekawa, Takahiro Hara, and Daichi Amagata
- Subjects
Service (systems architecture) ,Information retrieval ,lcsh:T55.4-60.8 ,Computer science ,business.industry ,Deep learning ,User modeling ,lcsh:Electronics ,lcsh:TK7800-8360 ,E-commerce ,Cross-domain recommender system ,Recommender system ,heterogeneous information network ,Domain (software engineering) ,deep neural networks ,User experience design ,e-commerce ,lcsh:Industrial engineering. Management engineering ,Word2vec ,Artificial intelligence ,business - Abstract
Many applications use recommender systems to predict user preferences, improve user experience, and increase the amount of sales. However, because of the cold-start problem, it is not easy to recommend items to new users accurately. Recommendation performance degrades in the case of users with little interaction, in particular latent users who have never used the service. To alleviate the cold-start problem, we develop a framework that combines an online shopping domain with information from an Ads platform. Our framework employs deep learning to build a cross-domain recommender system based on shared users in these two domains. This is the first attempt that models users based on shared users in online shopping and Ads domains for solving the user-cold start problem. We apply Word2Vec to turn textual information on users and items into latent vectors as their representations. The experimental results show the effectiveness of deep neural approaches with knowledge transferred from another domain for the cold-start problem. Textual information may contain useless information, and Word2Vec cannot capture some structural and semantic correlations between different users. Therefore, we propose R-metapath2Vec to enhance user modeling and use the Stacking model to integrate these two kinds of user representations. The experimental results demonstrate the effectiveness of our integration model: our framework can recommend products to users of another domain through Ads distribution in a more accurate level.
- Published
- 2020
38. FACTORS ASSOCIATED WITH THE USE OF 360-DEGREE LASER RETINOPEXY DURING PRIMARY VITRECTOMY WITH OR WITHOUT SCLERAL BUCKLE FOR RHEGMATOGENOUS RETINAL DETACHMENT AND IMPACT ON SURGICAL OUTCOMES (PRO STUDY REPORT NUMBER 4)
- Author
-
Dean Eliott, James A. Stefater, Daniel P. Joseph, Marianeli Rodriguez, Nora J. Forbes, Yoshihiro Yonekawa, Geoffrey G. Emerson, Srividya Kakulavarapu, Antonio Capone, Edwin H. Ryan, Jay C Wang, Claire Ryan, Omesh P. Gupta, and Patrick J. Mardis
- Subjects
Pars plana ,medicine.medical_specialty ,Visual acuity ,genetic structures ,medicine.medical_treatment ,Vitrectomy ,Scleral buckle ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Ophthalmology ,medicine ,Macular edema ,business.industry ,Retinal detachment ,Retrospective cohort study ,General Medicine ,medicine.disease ,eye diseases ,medicine.anatomical_structure ,030221 ophthalmology & optometry ,sense organs ,Epiretinal membrane ,medicine.symptom ,business - Abstract
PURPOSE To determine factors associated with 360-degree laser retinopexy (360LR) during primary pars plana vitrectomy ± scleral buckle for rhegmatogenous retinal detachment (RRD) and its impact on surgical outcomes. METHODS This is a multicenter, retrospective, interventional study. Patients undergoing primary pars plana vitrectomy or primary pars plana vitrectomy + scleral buckle for noncomplex primary RRD in 2015 were evaluated. Primary outcomes were single surgery anatomical success (SSAS) and final anatomical success. Secondary outcomes included final logarithm of the minimum angle of resolution visual acuity, epiretinal membrane formation, cystoid macular edema development, and number of subsequent vitrectomies. Multivariate regressions were performed. RESULTS Two thousand two hundred and forty-eight surgeries by 61 surgeons were included; of which, 516 underwent 360LR. Younger age (P = 0.01), more retinal breaks (P = 0.01), more extensive RRD (P < 0.001), and surgeon ID (P < 0.001) were significantly associated with 360LR. No significant associations between 360LR and single surgery anatomical success (P = 0.44), epiretinal membrane formation (P = 0.14), cystoid macular edema development (P = 0.28), or number of subsequent vitrectomies (P = 0.41) were found. Controlling for case complexity, 360LR was significantly associated with lower final anatomical success (P < 0.001) and worse final logarithm of the minimum angle of resolution visual acuity (P < 0.001). CONCLUSION Multiple factors influenced whether 360LR was performed during primary pars plana vitrectomy ± scleral buckle for RRD. However, 360LR was not associated with improved surgical outcomes, and in fact, it may be associated with poorer outcomes.
- Published
- 2019
39. Evaluation of a Novel Immunochromatographic Assay Using Monoclonal Antibodies against the Matrix Protein of Human Metapneumovirus
- Author
-
Noboru Sakai, Yasuhisa Odagawa, Atsushi Tame, Atsushi Manabe, Daisuke Sato, Hideaki Kikuta, Akiko Okamura, Akihito Ishizaka, Yasushi Akutsu, Takehiro Togashi, Tatsuhiro Tohmoto, Koichi Yasoshima, Nobuhisa Ishiguro, Keisuke Morita, Katsura Ishizu, Motoharu Yonekawa, Tatsuru Yamanaka, Naoko Nagano, Katsuki Azuma, Fujio Kakuya, and Akira Tsuchida
- Subjects
Myeloma protein ,medicine.drug_class ,viruses ,Monoclonal antibody ,General Biochemistry, Genetics and Molecular Biology ,Viral Matrix Proteins ,Human metapneumovirus ,Nasopharynx ,Medicine ,Humans ,Respiratory Tract Infections ,Immunoassay ,Viral matrix protein ,Paramyxoviridae Infections ,Respiratory tract infections ,biology ,medicine.diagnostic_test ,business.industry ,virus diseases ,Antibodies, Monoclonal ,Infant ,biology.organism_classification ,Virology ,respiratory tract diseases ,Monoclonal ,biology.protein ,Metapneumovirus ,Antibody ,business - Abstract
Background The aim of this study was to determine the sensitivity and specificity of a novel immunochromatographic (IC) assay (APD1806) using monoclonal antibodies against the matrix (M) protein of human metapneumovirus (hMPV) for detection of hMPV from nasopharyngeal swab samples based on the results of real-time RT-PCR. Methods Nasopharyngeal swab samples taken from 189 patients aged 0 - 5 years who were suspected of having respiratory tract infections associated with hMPV were used in this study. The samples were tested both by the IC assay and by real-time RT-PCR for detection of hMPV. Results The sensitivity and specificity of the IC assay for detection of hMPV were 88.8% (95/107) and 92.7% (76/82), respectively. Conclusions The IC assay using monoclonal antibodies against the M protein of hMPV is an accurate and fast assay that is suitable as a diagnostic tool for hMPV infection. The optimal timing of the IC assay is 12 hours or more after the onset of fever due to hMPV infection.
- Published
- 2021
40. Earliest pulmonary vein potential guided cryoballoon ablation is associated with better clinical outcomes than conventional cryoballoon ablation: a result from two randomized clinical studies
- Author
-
M Kanashiro, J Watanabe, Y Makino, Y Mizutani, H Ichimiya, J Yonekawa, Y Uchida, D Yamashita, and T Hiramatsu
- Subjects
medicine.medical_specialty ,business.industry ,medicine ,Radiology ,Cardiology and Cardiovascular Medicine ,business ,Cryoballoon ablation ,Pulmonary vein - Abstract
Background With regards to short-term outcome in atrial fibrillation (AF), the benefit of cryoballoon ablation (CBA) by pressing a balloon against the earliest pulmonary vein (PV) potential site during pulmonary vein isolation, (earliest potential [EP]-guided CBA) has been previously demonstrated. Objective The present study aimed to evaluate the long-term outcome of the EP-guided CBA. Methods This study included 136 patients from two randomized studies, who underwent CBA for paroxysmal AF for the first time. Patients were randomly assigned to the EP-guided and conventional CBA groups in each study. In the EP-guided CBA group, we pressed a balloon against the EP site when the time to isolation (TTI) after cryoapplication exceeded 60 s and 45 s in the first and second studies, respectively. The patients were followed up for 1 year after procedure. We compared the clinical outcomes between the EP-guided CBA group (68 patients) and the conventional CBA group (68 patients). Results No significant differences in baseline characteristics were observed between the two groups. Compared with the conventional CBA group, the EP-guided CBA group had a significantly higher success rate at TTI ≤90 s (98.5% vs. 90.0%, P Conclusions The EP-guided CBA approach can facilitate the ablation procedure and achieve low recurrence at 1-year after ablation. Funding Acknowledgement Type of funding sources: None. Earliest potential [EP]-guided CBAThe recurrence at 1-year after ablation
- Published
- 2021
41. American Society of Retina Specialists Clinical Practice Guidelines on the Management of Nonproliferative and Proliferative Diabetic Retinopathy without Diabetic Macular Edema
- Author
-
Charles C. Wykoff, Yoshihiro Yonekawa, Dimitra Skondra, Yasha S. Modi, Leo A. Kim, and Judy E. Kim
- Subjects
medicine.medical_specialty ,business.industry ,Diabetic retinopathy ,medicine.disease ,eye diseases ,Article ,Clinical trial ,Diabetes management ,Diabetes mellitus ,medicine ,Risk factor ,Lost to follow-up ,Adverse effect ,Intensive care medicine ,business ,Retinopathy - Abstract
PURPOSE: Nonproliferative (NPDR) and proliferative diabetic retinopathy (PDR) without diabetic macular edema (DME) affect millions of individuals living with diabetes throughout the world. There is increasing data on various management strategies for such patients, but there is limited consensus on how the data should be adopted into clinical practice. METHODS: This literature review and editorial presents and synthesizes the current evidence for various management paradigms for NPDR and PDR without DME. RESULTS: Retina specialists are an integral member of the diabetes management team, and should encourage patients on the importance of glycemic and cardiovascular optimization for both systemic and retinopathy risk factor reduction. The diabetic retinopathy severity scale (DRSS) is now an approvable endpoint for clinical trials in the United States, therefore becoming more clinically relevant. For PDR without DME, the Diabetic Retinopathy Study (DRS) and the Early Treatment Diabetic Retinopathy Study (ETDRS) established the standard of care with panretinal photocoagulation (PRP). Laser parameters have since evolved to include less intense and earlier intervention. Studies have recently demonstrated that anti-vascular endothelial growth factor (VEGF) treatment of PDR is effective at regressing neovascularization and improving DRSS levels in many patients. Further evidence is required to determine optimal treatment frequency, duration, and retreatment criteria, in the real world. There are concerns for adverse events in patients being lost to follow up during anti-VEGF treatment. For NPDR without DME, the standard of care has been a wait-and-watch approach. Data within the DRS and the ETDRS suggest that PRP for severe NPDR can be an option for select patients as well. Multiple clinical trials have now demonstrated that anti-VEGF treatment can improve the DRSS score in NPDR. Further studies are required to assess whether this positively affects long-term visual outcomes, and whether the benefits outweigh the risks in the real world for routine use. CONCLUSIONS: There is cumulative evidence demonstrating the efficacy of various treatment options for NPDR and PDR without DME. Currently, patients would most likely benefit from thoughtful management strategies that are tailored to the individual patient.
- Published
- 2021
42. Telemedicine for Retinopathy of Prematurity in 2020
- Author
-
J. Peter Campbell, Theodore Bowe, Yoshihiro Yonekawa, and Cindy Ung
- Subjects
Pediatrics ,medicine.medical_specialty ,Telemedicine ,business.industry ,Visual impairment ,MEDLINE ,Retinopathy of prematurity ,medicine.disease ,Article ,03 medical and health sciences ,0302 clinical medicine ,030225 pediatrics ,030221 ophthalmology & optometry ,medicine ,medicine.symptom ,business - Abstract
Purpose: Retinopathy of prematurity (ROP) is the leading cause of visual impairment in premature infants, and middle-income nations are currently experiencing the “third epidemic” of ROP. Screening programs are essential to prevent negative visual outcomes, but screening efforts require a great amount of resources from healthcare systems and are difficult to marshal, particularly in geographically isolated or resource-limited settings. Telemedical screening programs using remote digital fundus imaging (RDFI) systems hold the promise of alleviating many of the burdens that currently make screening for ROP logistically challenging. Methods: Literature review of the current evidence for RDFI telescreening for ROP, with editorial discussion and recommendations. Results: In this review, we summarize the robust body of literature regarding the efficacy of RDFI, the feasibility of telescreening programs, and experiences from current live telescreening programs. We discuss the strengths and limitations of the current evidence and of the screening programs and consider the best practices in developing de novo telemedical screening programs for ROP. The review concludes with a discussion of promising future areas of research and development. Conclusions: RDFI ROP screening programs can be accurate and reliable. They show promise in improving many current challenges in screening infants for ROP, may be able to improve some aspects of care, and have been demonstrated to be cost-effective.
- Published
- 2021
43. Exudative Retinal Telangiectasia Associated With Leri-Weill Dyschondrosteosis
- Author
-
Yoshihiro Yonekawa, Rebecca R. Soares, and Maxwell S. Stem
- Subjects
Homeodomain Proteins ,medicine.medical_specialty ,business.industry ,medicine.disease ,Osteochondrodysplasias ,Ophthalmology ,Retinal telangiectasia ,Medicine ,Humans ,Telangiectasis ,business ,Léri–Weill dyschondrosteosis ,Growth Disorders - Published
- 2021
44. Repair of Rhegmatogenous Retinal Detachment Following Globe Perforation by Retrobulbar Anesthesia
- Author
-
Yoshihiro Yonekawa, Peter H. Tang, Nicolas A. Yannuzzi, Swarup S. Swaminathan, Rehan Hussain, Jayanth Sridhar, and Jason Hsu
- Subjects
Pars plana ,Proliferative vitreoretinopathy ,medicine.medical_specialty ,genetic structures ,medicine.medical_treatment ,Perforation (oil well) ,Retrobulbar block ,Vitrectomy ,Cataract Extraction ,03 medical and health sciences ,0302 clinical medicine ,Ophthalmology ,medicine ,Humans ,Anesthesia ,Local anesthesia ,Aged ,Retina ,business.industry ,Retinal Detachment ,Retinal detachment ,medicine.disease ,Eye Injuries, Penetrating ,eye diseases ,medicine.anatomical_structure ,030221 ophthalmology & optometry ,Female ,sense organs ,business ,Tomography, Optical Coherence - Abstract
Globe perforation following retrobulbar or peribulbar anesthetic injection is a rare but dreaded complication that often results in suboptimal visual outcomes. This video describes a 72-year-old woman who sustained a globe perforation during retrobulbar block in the setting of cataract extraction and later developed a retinal detachment. The retina was repaired with pars plana vitrectomy and silicone oil, resulting in a favorable visual outcome. The authors discuss various modes of local anesthesia for vitreoretinal surgery, risks for globe perforations, and how to approach retinal detachment secondary to needle perforations, which are complex cases at high risk for proliferative vitreoretinopathy.
- Published
- 2020
45. A case of overlapping adult‐onset linear scleroderma and Parry‐Romberg syndrome presenting with widespread ipsilateral neurogenic involvement
- Author
-
Koji Shinoda, Takuya Matsushita, Shoko Sadashima, Saeko Inamizu, Hirofumi Ochi, Noriko Isobe, Toru Iwaki, Masutaka Furue, Yoshinao Oda, Ryo Yamasaki, Tomomi Yonekawa, Yuki Kuma, Jun Ichi Kira, and Gaku Tsuji
- Subjects
Muscle biopsy ,integumentary system ,medicine.diagnostic_test ,business.industry ,Parry–Romberg syndrome ,General Medicine ,Anatomy ,medicine.disease ,Pathology and Forensic Medicine ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Atrophy ,Ptosis ,030220 oncology & carcinogenesis ,Skin biopsy ,medicine ,Linear Scleroderma ,Neurology (clinical) ,Eyelid ,medicine.symptom ,skin and connective tissue diseases ,business ,Localized Scleroderma ,030217 neurology & neurosurgery - Abstract
Linear scleroderma is a variant of localized scleroderma. We report a 43-year-old woman who had developed left arm weakness and linear scleroderma on her back during pregnancy at 25 years of age, followed by left hemifacial atrophy and left leg weakness. She had multiple linear scleroderma lesions on her trunk and left limbs, left eyelid ptosis, impairment of vertical movement and abduction of the left eye, left hemifacial atrophy, and weakness and atrophy of the sternocleidomastoid, trapezius, and proximal limb muscles on the left side. On serology, antibodies to U1-ribonucleoprotein and Jo-1 were positive; anti-scleroderma-70 antibody was negative. Skin biopsy demonstrated increased hypertrophic collagen fibers without inflammatory infiltrates. Needle electromyography of left limb muscles revealed mild neurogenic patterns; left quadriceps muscle biopsy showed chronic neurogenic changes. Brain magnetic resonance imaging revealed mild left hemispheric atrophy. This is a rare case of linear scleroderma and Parry-Romberg syndrome presenting with widespread ipsilateral neurogenic manifestations.
- Published
- 2019
46. A Multicenter Study of Pediatric Macular Holes: Surgical Outcomes With Microincisional Vitrectomy Surgery
- Author
-
Yoshihiro Yonekawa, Sarah P. Read, Kimberly A. Drenser, Emmanuel Chang, Robert A. Sisk, Nikisha Kothari, Eric Nudleman, Philip J. Ferrone, Prethy Rao, Caroline R. Baumal, Audina M. Berrocal, Antonio Capone, and William E. Smiddy
- Subjects
medicine.medical_specialty ,genetic structures ,business.industry ,medicine.medical_treatment ,Vitrectomy ,eye diseases ,Surgery ,03 medical and health sciences ,0302 clinical medicine ,Multicenter study ,030221 ophthalmology & optometry ,medicine ,Original Manuscripts ,business ,030217 neurology & neurosurgery - Abstract
Purpose:Pediatric macular holes occur often related to trauma and rarely require surgical intervention. The purpose of the present study was to evaluate outcomes of microincisional vitrectomy surgery.Methods:A multicenter retrospective consecutive case series was conducted of pediatric patients undergoing surgery for macular hole repair.Results:A total of 31 eyes from 8 centers were included in this study. The mechanism of macular hole development was blunt trauma in 30 eyes (97%) and industrial laser in 1 eye (3%). The rate of anatomic closure after primary vitrectomy was 81% (25 eyes); the final anatomic closure rate after a secondary vitrectomy was 94% (29 eyes). There was a statistically significant improvement in visual acuity from initial presentation (20/164) to final follow-up (20/100) ( P = .009).Conclusions:Microincisional vitrectomy surgery for pediatric macular holes results in substantial anatomic success and modest improvement in visual acuity.
- Published
- 2019
47. A Surgical Technique for the Management of Tractional Retinal Detachment in Aggressive Posterior Retinopathy of Prematurity Treated With Intravitreal Bevacizumab
- Author
-
Antonio Capone, Benjamin J. Thomas, Yoshihiro Yonekawa, and Irina De la Huerta
- Subjects
medicine.medical_specialty ,Fundus Oculi ,MEDLINE ,Angiogenesis Inhibitors ,Gestational Age ,Retina ,Text mining ,Ophthalmology ,Humans ,Medicine ,Retinopathy of Prematurity ,Fluorescein Angiography ,Intravitreal bevacizumab ,Tractional retinal detachment ,business.industry ,Infant, Newborn ,Retinal Detachment ,Follow up studies ,Gestational age ,Retinopathy of prematurity ,General Medicine ,medicine.disease ,Bevacizumab ,Receptors, Vascular Endothelial Growth Factor ,Intravitreal Injections ,business ,Follow-Up Studies - Published
- 2019
48. Degenerative Peripheral Retinoschisis: Observations From Ultra-Widefield Fundus Imaging
- Author
-
Tahsin Khundkar, Yoshihiro Yonekawa, David Xu, Jeremy D. Wolfe, Aristomenis Thanos, George A. Williams, Antonio Capone, David Sarraf, Sirichai Pasadhika, Lisa J. Faia, Bozho Todorich, Cindy Ung, and Atul Jain
- Subjects
Adult ,Diagnostic Imaging ,Male ,medicine.medical_specialty ,Visual acuity ,Retinoschisis ,Visual Acuity ,Fundus (eye) ,Multimodal Imaging ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Retinal Examination ,Ophthalmology ,Photography ,medicine ,Humans ,Fluorescein Angiography ,Aged ,Retrospective Studies ,Aged, 80 and over ,Retina ,medicine.diagnostic_test ,business.industry ,Optical Imaging ,Retinal ,Middle Aged ,Fluorescein angiography ,Autofluorescence ,medicine.anatomical_structure ,chemistry ,Angiography ,030221 ophthalmology & optometry ,Female ,medicine.symptom ,business ,Tomography, Optical Coherence - Abstract
BACKGROUND AND OBJECTIVE: To describe the ultra-widefield (UWF) imaging characteristics of patients with degenerative peripheral retinoschisis (DPR) using Optomap technology. PATIENTS AND METHODS: In this multicenter, retrospective, noncomparative, consecutive case series, eligible patients underwent detailed retinal examination including indirect ophthalmoscopy. UWF fundus imaging, including color fundus photography, autofluorescence, and angiography, was performed using standardized protocols and findings were recorded and reviewed and analyzed. RESULTS: A total of 35 patients (58 eyes) with DPR were identified who underwent 55 sessions of UWF imaging. Mean age was 65 years, and the inferotemporal quadrant was most commonly affected (74% of eyes). Of these patients, 31 underwent fluorescein angiography and 90% of these studies illustrated abnormalities in the area affected by the schisis. The most common finding was retinal vascular leakage originating from the deep capillary plexus observed in 29 eyes (93.5%). CONCLUSIONS: UWF imaging enables a more detailed identification of the clinical features associated with DPR and provides simple, practical, and noninvasive tools to monitor progression of disease. The breadth of retinal vascular complications identified with fluorescein angiography may suggest an important vascular component associated with the pathogenesis of this entity. [ Ophthalmic Surg Lasers Imaging Retina . 2019;50:557–564.]
- Published
- 2019
49. Characterization of Epiretinal Proliferation in Full-Thickness Macular Holes and Effects on Surgical Outcomes
- Author
-
Antonio Capone, Demetrios G. Vavvas, Lisa J. Faia, Yoshihiro Yonekawa, Dean Eliott, George A. Williams, Jay Wang, Jeremy D. Wolfe, Maria A. Woodward, Miin Roh, Adam J. Weiner, Shizuo Mukai, Lucy H. Young, Maxwell S. Stem, Jason Comander, Leo A. Kim, David M. Wu, Bruce R. Garretson, Alan J. Ruby, Kimberly A. Drenser, Ivan J. Lee, Cindy Ung, Esther Lee Kim, Mohammad Dahrouj, Natalie T Huang, Tarek S Hassan, and Ivana K. Kim
- Subjects
Adult ,Male ,Pars plana ,medicine.medical_specialty ,Visual acuity ,Adolescent ,genetic structures ,medicine.medical_treatment ,Visual Acuity ,Retinal perforation ,Vitrectomy ,Endotamponade ,Article ,03 medical and health sciences ,0302 clinical medicine ,Ophthalmology ,medicine ,Humans ,Aged ,Retrospective Studies ,030304 developmental biology ,Aged, 80 and over ,0303 health sciences ,business.industry ,Epiretinal Membrane ,Retrospective cohort study ,Middle Aged ,Retinal Perforations ,medicine.disease ,eye diseases ,medicine.anatomical_structure ,Case-Control Studies ,030221 ophthalmology & optometry ,Female ,Full thickness ,sense organs ,Tamponade ,Epiretinal membrane ,medicine.symptom ,business ,Tomography, Optical Coherence ,Follow-Up Studies - Abstract
PURPOSE: Epiretinal proliferation is a distinct clinical entity from epiretinal membrane that is classically associated with lamellar macular holes, but its prevalence and association with full-thickness macular holes (FTMH) have not been well described. We characterize MHEP macular hole associated epiretinal proliferation (MHEP) and its effects on long-term surgical outcomes. DESIGN: Multi-center, interventional, retrospective case control study. SUBJECTS: Consecutive eyes that underwent surgery for FTMH with a minimum of 12-months follow-up. METHODS: All eyes underwent pars plana vitrectomy, removal of any epiretinal membranes, and gas tamponade, with or without internal limiting membrane peeling. Spectral domain optical coherence tomography imaging was obtained pre- and post-operatively. MAIN OUTCOME MEASURES: Improvement in visual acuity and single surgery hole closure rates in eyes with, versus without, MHEP at 12 months. RESULTS: 725 charts were analyzed, and 113 patients met inclusion criteria. Of 113 eyes with FTMH, 30 (26.5%) had MHEP. Patients with FTMH and MHEP were older (P < 0.002), more often male (P = 0.001), and with more advanced macular hole stages than those without MHEP (P = 0.010). A full posterior vitreous detachment was more common in eyes with MHEP (P < 0.004). FTMH with MHEP had significantly less improvement in visual acuity 12-months postoperatively (P = 0.019) with higher rates of ellipsoid and external limiting membrane defects (P < 0.05) and with a higher rate of failure to close with one surgery compared to FTMH without MHEP (26.7% versus 4.8% [P = 0.002]). Peeling the internal limiting membrane was associated with improved rates of hole closure in FTMH with MHEP (P < 0.001). Multivariable testing confirmed that the presence of MHEP was an independent risk factor for less visual improvement (P = 0.031), single-surgery non-closure (P = 0.009), and that ILM peeling improved single-surgery closure rates (P = 0.026). CONCLUSIONS: We found that FTMH with MHEP has poorer anatomic and visual outcomes after vitrectomy compared to FTMH without MHEP. ILM peeling was associated with improved closure rates and should be considered when MHEP is detected preoperatively.
- Published
- 2019
50. Predictive Factors for Completion of TPF Induction Chemotherapy in Patients With Locally Advanced Head and Neck Cancer
- Author
-
Hiroki Mitani, Hirofumi Fukushima, Toru Sasaki, Kenji Nakano, Akira Seto, Hiroyuki Yonekawa, Shunji Takahashi, and Wataru Shimbashi
- Subjects
Adult ,Male ,Oncology ,Cancer Research ,medicine.medical_specialty ,Drug-Related Side Effects and Adverse Reactions ,Docetaxel ,Disease-Free Survival ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Antineoplastic Combined Chemotherapy Protocols ,medicine ,Humans ,Aged ,business.industry ,Hazard ratio ,Head and neck cancer ,Induction chemotherapy ,Induction Chemotherapy ,General Medicine ,Middle Aged ,Prognosis ,medicine.disease ,Primary tumor ,Confidence interval ,Tolerability ,Head and Neck Neoplasms ,Fluorouracil ,030220 oncology & carcinogenesis ,Carcinoma, Squamous Cell ,Female ,Cisplatin ,Neoplasm Recurrence, Local ,business ,medicine.drug - Abstract
Background Induction therapy with docetaxel, cisplatin and fluorouracil (TPF) is a treatment option for locally advanced head and neck cancer (LAHNC), but it is not known which patients are appropriate for TPF. Patients and methods We retrospectively reviewed the records of patients with LAHNC who underwent induction TPF, and evaluated factors predictive of the completion of TPF treatment (defined as ≥3 cycles administered). Results Of the total 93 enrolled patients, 73 (78.5%) achieved therapy completion. In a multivariate analysis, hypolaryngeal/ laryngeal primary tumor site was a negative predictive factor (hazard ratio(HR)=0.32, 95% confidence interval(CI)=0.11-0.96, p=0.041) and body mass index ≥22 kg/m2 was a positive predictive factor (hazard ratio=3.51, 95% confidence intervaI=1.04-11.83, p=0.043) of TPF completion. Conclusion For patients with LAHNC, oropharyngeal primary tumor site and high body mass index can be used to predict TPF completion and may contribute to decisions on the indications for TPF in terms of safety and tolerability.
- Published
- 2019
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.